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Abstract 
Ischemic stroke is a debilitating medical event with the majority of suffe rers 
experiencing long-term disability and motor impairments. While front line treatment such 
as anti -embo lic medication and rehabilitation can improve the condi tion, many 
indi viduals remain signifi cantly di sabled. Experimental therapies involving genetic 
interventions hold potential for treatment of ischemic stroke, but many therapies go 
untested due to a lack of small cortical ischemic injury models in the mo use. Models of 
ischemic stroke should be small , reproducible and produce measurable behavioural 
defic its in order to see recovery aft er therapy. Addi tionally, the injury sho uld avoid 
damage to neural precursor cells (NPCs) which are often targeted by genetic approaches 
to modify their survivability and plastic ity post stroke. Thi s hi ghlights the demand for a 
small cortical ischemic injury mode l in the mouse, w here transgenic techno logies can be 
used to the ir full potenti al. Existing models of ischemic injury, such as middle cerebral 
artery occlusion (MCAO) produce large amounts o f ischemic damage, but may pro ve 
more di ffi cult to regenerate and/or eliminate behav io ural deficits post-stroke. Endothel in-
1 (ET- 1 ), a potent vasoconstrictive peptide, was used to induce ischemia in the mouse 
cortex. ET- 1 injected into the mouse cortex produced a sm all but significant infarct. To 
determine whether ET-1-induced infa rcts could produce behavioura l defic its, injections 
were targeted to the mouse fo relimb motor cortex (FMC) and the amo unt of infarct 
encompassing the FMC was correlated with behavioural de fi cits. To ana lyze this, two-
dimensiona l topo logical maps of cortical infarct depth were created and the deeper parts 
o r injury correlated with behavioural deti cits. Using standard behavioura l tests adapted 
for use with mice, the mo use sta ircase test was shown to correlate with FMC infarct 
location and depth. The mouse cylinder test of fo re limb asymmetry did not corre late with 
FMC infarct location and depth; despite thi s, a new ana lysis termed paw-dragging did 
corre late with FMC infa rct location and depth. The results demonstrated that the FMC is 
functionally subdivided such that staircase defici ts corre lated wi th damage to the anterior 
FMC as opposed to the posterior FMC. As well , a small cortical infarct produced by ET- l 
I I 
induced PC proli fe ration and migration. At 14 days post-injection, there were 
significantly more neuroblasts in the subventricular zone (SVZ) and the corpus callosum 
ipsilateral to injury. As NPCs proliferate and migrate toward E'f-l-induced cortical 
infa rcts, there is potential for therapeutic intervention to improve regeneration of lost 
tissue. This study provides a foundation for manipulating NPCs and analyzing their 
integration into the peri-infarct cortex. 
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Chapter I: Introduction 
1.1 Adult ncurogcnesis and stem cell s in the adult brain 
1.1.1 - Stem cells in the adult CNS 
The adult brain is capable of regenerating cell s throughout life. The prior 
consensus, that neurons were not generated after birth, was questioned repeatedl y during 
the 1960s and ultimately upended in the 1990s. The candidate cell type which can 
generate neurons after birth is the neural stem cell (NSC). eural stem cells are self-
renewing cell s which have the ability to differentiate into multiple brain-specific cell 
subtypes: neurons, astrocytes and oligodendrocytes (Reynolds & Weiss, 1992). These 
ce ll s continuously suppl y parts of the brain with new neurons and glial ce lls throughout 
life . In the 1960s, work with 31-1-thymidine (A ltman, 1962) autoradiography showed 
signal-retaining cells within the dentate gyrus of the adul t rat hippocampus vvhich 
declined in number with age (Altman & Das, 1965). Cell s within the adult rat 
subventricular zone (SVZ) lining the lateral ventricles were also observed to be label-
retaining and declined in number with age (Altman, 1963; Altman & Das. 1966). As well, 
labeled cell s decreased in number rapidly after the 31 !-thymidine injection suggesting a 
fate of death or migration. Evidence for a path of migratory cell s toward the olfactory 
bulb (rostral migratory stream or RMS) was found using autoradiography (Altman & 
Das, 1969). Whi le Altman's studies correctl y identified mitotic characterist ics of the 
SVZ, the type of cells within the SVZ was not yet determined. 
eural stem cells were characterized as SVZ-deri ved cells which could proliferate 
in the presence of EG F as well as differentiate and express markers of neurons and 
astrocytes such as enolase-2 and glial fibrill ary acid ic protein (GFAP), respectively 
(Reynolds & Weiss, 1992). The proliferative cell s of the SVZ were demonstrated to be 
stem cell s by the ability to self-renew indefinitely in the presence of EGF, and the abili ty 
to remai n multipotent (Reynolds & Weiss, 1996). The proliferative population could be 
repleni shed after ablation and was considered to be primarily neural progenitor cells 
(NPCs). These cells are fate-restricted progeny of stem cell s with a finite capac ity to self-
renew. A small quiescent population of SVZ cells were found to comprise the stem cell 
population (Morshead eta!. , 1994). Together the stem cell population and the progenitor 
population are termed "neural precursor cell s" ( PC) . The current study will invest igate 
new·ogenesis primaril y in the SVZ. 
1.1.2 - T he SVZ ni che 
The PCs w ithin the SVZ are supported by multiple cell types which maintain 
their homeostasis. Thi s heterogeneous population of cell types, or ··niche" is maintained 
into ad ulthood and is responsible for the self-renewal of NSCs and maturation of their 
progeny. NPCs are supported by a unique vasculature . by n iche astrocytes and the 
ventricular ependyma. Through regulation of prolife ration, growth and stem cell identity, 
the SVZ persists thro ugho ut one's li fespan. 
T he SVZ is located between the ciliated ependymal cell layer facing the ventricle 
and the striata l parenchyma. Within the niche, there are four major cell-types (Fig 1.1). 
Type B cell s are the resident NSCs (less than I% of cell s, Morshead et al. , 1994) which 
di vide slowly and give rise to Type C cell s. Using cumulati ve doses of 5-
bromodeoxyuridine (BrdU, a thymidine ana log), a rapidly dividing progenitor population 
- the type C ce ll population was described (Morshead & van der Kooy. 1992). Type C 
cells, a lso known as the transit-amplifying cells, give rise to Type A ce ll s. Type A cells 
are neuro blasts which mi grate a long the RMS to the o lfactory bulb, where they terminall y 
d ifferentiate into neurons (Fig. 1. 1 ). Glial Fibrill ary Acid Prote in (G FAP)+ cells within 
the SVZ were found to be the residing NSC in the SVZ. These GFAP+ ce ll s can form 
neurosphcres in vitro (Doetsch ct a!. , 1999a; Morshead et a l. , 2003) and can repopu late 
the lineage ofC and A cell s (Doetsch ct al. , 1999b). Type E cell s are the ependymal cells 
that line the ventricular wall of the SVZ (Doetsch et a l. , 1997) and have low proliferati ve 
ability and no multipotency (Chiasson ct al. , 1999) under normal c ircumstances. The cel l 
types described above are characterized by specific immunohistoc hemical markers, 
electron-micrograph markers and di stinct cell cycle lengths. Type B cell s express GFAP. 
2 
f igure l . l : Morphology and lineage of the SVZ Niche. eural stem cells (type B) di vide 
slowly and give ri se to transit-amplifying cells (type C). which divide rapidly. Transit-
amplifying cell s di vide and differentiate into ncuroblasts (type A), which gain the ability 
to migrate in chains. Ependymal cell s (type E) face the lateral ventri cles. fo rm tight 
j unctions with each other, and do not belong to the neural stem cell lineage (adapted r·rom 
Doetsch et al. , l999a). 
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Figure 1.1 
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Sox2 1 and cstin . but not di stal-less 2 (Dlx2). The C cell s (transit-ampli fy ing cells) 
express (Dlx2) but not polysialated neural cell adhesion molecule (PSA-NCAM) like 
their neuroblast progeny (Table 1.1, modi fi cd from Okano ct al. , 2007). Neuroblasts 
express PS/\-NC/\M and Doublecortin (Dcx) and migrate toward the olfactory bulb to 
become mature neurons. which express cu . Electron micrographs reveal other 
morphological differences: neuroblasts have small elongated nuclei and a dark cytoplasm, 
while type B and C cell s have large nuclei and a bright cytoplasm. Cell cycle length can 
also di stinguish between GFAP+ type B cell s and Dlx2+ type C cells in that their cell 
cycle times arc 28 days (Craig et al. , 1994) and 12.7 hours respectively (Morshead & van 
der Kooy, 1992). Targeting and experimenting with NPCs in the SVZ is possible using 
these precise markers. 
The SVZ niche is regulated by a host or growth-promoting lactors. Within the 
cerebrospinal Ouid. Insulin-like growth facto r-11 (IG F-II) regulates growth by binding to 
receptors on NSC primary cilia proj ecting into the lateral ventricle (Lehtinen et a!.. 20 II ). 
Table 1.1 : Markers o r the SVZ lineage. 
Neural Transit- Neuroblasts Immature Neuron 
Stem Cell ampl ifying Neuron 
Cell 
GFAP + 
Sox21 -1 -1 + 
Nestin -1 + 
Dlx2 -1 
PSA-NCAM 
Doublecortin 
BetaJTI-Tubulin 
NeuN + 
Electron- Large Large Small 
micrograph deta ils Nucleus uclcus Nucleus 
Bright Bright Dark 
Cytoplasm Cytoplasm Cytoplasm 
Cell Cycle Time 28 days 12.7 hours Post-mi totic Post -mitotic Post-mitotic 
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EG F and FG F2 bo th increase proliferation within the intact bra in (Craig et a l. , 1996; 
Kuhn et a l. , 1997) and have a lso been shown to be crucial factors for mainta ining adult 
PCs in a pro li fe rating undi fferentiated state in vitro (Gritt i et al.. 1995 ; Reynolds & 
Weiss. 1992). Notch pathway acti vation is required fo r self- renewal ofNSCs (Imayoshi 
ct a l. , 201 0). A variety of o ther ligands regulate prol iferation in the SVZ, including Sonic 
Hedgehog (Pa lma et al. , 2005), Wnt ligands (Adachi et al. , 2007) and vascu lar 
endothelial growth factor (Jin et al., 2002). The pro liferation in the SVZ directl y 
contributes to the maturation of olfactory bulb interneurons, as newborn neuroblasts 
migrate toward the olfac tory bulb. 
1.1 .3 - SVZ progeny repopulate the olfac tory bul b interneurons via the RMS 
ew neurons, derived from SVZ neuroblasts, develop within the olfactory bulb. 
In particular these neuro ns are fo und wi thin the granul e and peri glomerular layers. 
Between the SVZ and the o lfactory bulb, neuroblasts fo rm a long moving chain - the 
RMS. In 1994, the RMS was di scovered to consist of SVZ de rived ncuroblasts (Lois & 
1\lvarez-Buylla, 1994). Thi s led to a series of mechani stic d iscoveries about how NPCs 
become o lfactory bul b neurons. Using immunohi stochemical analysis, neuroblasts were 
observed to migrate in a chain-like procession sheathed in a GFAP+ astrocyte cage (Lois 
et al. , 1996) . Cha ins of migrating neuroblasts are fo und throughout the SVZ and converge 
at the RMS . To demonstrate thi s, NPCs expressing LacZ under the neuron-specific 
eno lase promoter were grafted into the caudal SVZ o f' wild-type animals. This resu lted in 
granule and pe ri glomerul ar labe ling within the olfac tory bu lb thirty days after the graft 
(Doetsch & 1\lvarcz-Buy lla, 1996). While many factors invo lved in proliferation and 
migration have been e lucidated, little is known about the regulation of survival ofNPCs. 
The option to live or die by apoptosis is integrated through the Bcl-2 fam ily of prote ins. 
Understanding which factors mediate a NPC's fate to live or die could ul timately have 
therapeutic benefi ts for neurodegenerative disease. 
1.2 - Ischemic stroke 
6 
Stroke results from an interruption of blood flow to the brain (ischemic) or 
busting of blood vessels within or around the brain (hemorrhagic) causing cell death. 
Strokes are commonly ischemic (87%), and most often caused by embolism. A minority 
of strokes are hemorrhagic ( 13%), in the case where a blood vessel is broken by trauma, 
hypertension or the result of a ruptured aneurysm (Rosamond et al. , 2008). The majority 
of ischemic strokes are serious if not fatal: 18% of patients di e post stroke. The remaining 
82% of stroke patients survive. While 42% of patients return to their li fe with little to no 
impairment, 40% are admitted to long-term care. Overall statistics suggest that l in 18 
deaths are stroke-related (Roger et al. , 20 11 ). Age is one of the most pertinent predictors 
of stroke - ri sk of stroke doubles every ten years past the age of 55 (Sacco et al. , 1997). 
The Canadian population is aging rapidly: population growth for those 65 and older has 
been 14.1% contrasted with the overall Canadian population growth rate of 5.9% between 
2006 and 20 11 (Stati stics Canada, 20 12). As a result. the burden of stroke on the health 
care system is becoming a more pressing issue 
The current front line treatment for acute ischemic stroke is ti ssue-plasminogen 
activator (t-PA). T-PA is effective within a 4.5 hour window after ischemic stroke, and 
serves to break down fibrin clots and mitigate stroke-related symptoms by activating 
serum plasmin. Effi cacy is greatly reduced when given 3 hours post stroke and when 
given after 4.5 hours there is no significant effect. Despite this being the front line 
treatment fo r ischemic stroke, reperfusion occurs onl y 46% of the time (Vivien et al, 
20 11 ). Additionall y, there is a 6.4% chance of intracerebral hemorrhage - with a 50% 
survival rate if this occurs. While t-PA is a valuable front line treatment, many patients do 
not arrive in a hospital in time for t-PA to be effective. As well , onl y 32% of patients 
given t-PA have an improved clinical outcome. The necessity for developing therapies 
which are effective outside the 4.5 h window oft-PA is paramount. Apart from acute 
pharmacological therapy with t- Pi\, behavioural rehabilitati on is able to restore some lost 
functionality. As behavioural therapy does not result in a complete recovery, new 
investigations invo lve repairing the site of injury. Understanding the cellular 
pathophysiology of ischemic stroke is critical in developing therapies preventing cell 
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death or regenerating lost cells. 
1.2 .1 -Pathophysio logy of ischemic stroke 
The pathophysiology of ischemic stroke consists primarily o f neuronal death, 
when cerebral blood now (CBF) drops below a threshold . Necrotic cell death occurs 
wi thin the core o f the ischemic region as early as 3h post-i schem ia after the permanent 
occlus ion of the middle cerebral artery in the rat (Lipton, 1999). eurons surrounding 
thi s region are vulnerable to tox ic metabolites released from dying ne urons - this is the 
penumbra, characterized by a prolonged, mostly apoptotic, mode of cell death. The extent 
to w hi ch perfusion is reduced, as well as the time during which the artery is occluded 
determine the extent of cell death. 
Damage begins after arteri al occlusion, resulting in a core of necrotic tissue 
caused by loss of perfusion and inflammation. This damage is first seen at about 3h post-
occl usion in ra ts, w hich corresponds to the effective time course oft-PA in humans 
(indicated for less than 3 h after onset of symptom s). The core of the ischemic region is 
'" infarcted'·. a term describing dead and dam aged tissue. The infarct is characteri zed 
hi stologically by pale cresyl vio let staining. which is associated w ith necrosis and 
vacuolization of neurons and g lia (Lipton, 1999), as well as energy failure (ATP 
depletion), less than 15-20% normal CBF and irreversible tissue damage (Lipton, 1999; 
Moskowitz eta!. , 201 0). Surrounding the core is the penumbra, a partially ischemic 
region which is vulnerable to toxic metabolites and inflammation within the core (Fig 
1.2). Cells within the penumbra maintain i\TP ho meostasis and membrane polari ty 
(i\strup et a!. , 198 1 ). The penumbra receives between 15% to 40(% of normal CI3F which 
causes acti on potentials to cease (Astrup et al.. 1977). The durati on of ischemia wi thout 
reperfusion affects how and when ne urons in the penumbra die. After permanent artery 
occlus ion, the infarcted core is vis ible within 3-1 2h. T he infarct then spreads to 
encompass most of the penumbra after 6-24h from the time of artery occlus ion, and 
expands through the remaining penumbra over 24-72h (up to 30% o f the infarct volume). 
By limiting the time of artery occlusion, cell death can be prevented or delayed . 
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Figure 1.2: Diagram of ischemic stroke - core vs penumbra. (A) The necrotic core forms 
within hours, while the penumbra is viable but has no neural activity. (B) Between 24-
72h post-ischemia, the infarct has encompassed most of the penumbra. Light gray 
denotes viab le tissue with less than 40% normal CBF. Dark gray denotes dead (infarcted) 
ti ssue. 
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T-PA is useful in preventing cell death because it limits the amount o r time that arteries 
are occluded. After l 0-20 minutes of artery occlusion a minority of neurons within the 
core are necrotic . After an hour of artery occlusion. the infarct encompasses the core and 
after a 2-3h artery occlusion the infarct will expand into the penumbra (though it expands 
more slowly than permanent ischemia, Lipton, 1999). Viabi lity of the penumbra 
therefore. in the absence of treatment, is ti ghtl y linked to the amount of time before 
normal blood llow is restored. The penumbra is a therapeut ically use ful region because it 
is possible to prevent cell s within it from dying. Timely administration of t-PA is an 
important factor in preventing penumbral cell death. 
The type of cell death in ischemic stroke varies temporally. ecrosis is the more 
predominant form of cell death in older animals (Yuan. 2009). Using common carotid 
artery occlusion, it was shown that older rats develop more necrotic death within the 
hippocampus than younger rats, which had more apoptotic cell death (Liu ct al. , 2004). 
Though the levels of cerebral blood ilow were not examined in this study, cell death 
peaked at 24-48h post-ischemia, suggesting the region of interest is the penumbra. The 
penumbra has suffi cient perfusion to keep cell s alive (Moskowitz ct al. , 20 I 0); however, 
to:x ic ex trace llular signals such as glutamate released fro m the necroti c core can induce 
additional neurons to undergo necrotic, apoptotic and excitotox ic cell death . Apoptotic 
cell death is associated with mild lesions and brief ischemic insults (Moskowitz et al. , 
20 I 0) and occurs predominantl y in the penumbra (Dirnagl et al. , 1999; Yuan, 2009). Most 
apoptotic cell death occurs between 24-72h post-ischemia, but levels can be significant ly 
maintained over a week afterward (Dirnagl et al. , 1999, Liu et al. , 2004). Due to the 
viability of the penumbra a Ctcr stroke. there is therapeutic interest in using an ti -apoptotic 
proteins to prevent apoptosis during thi s time. 
1.2.2 Apoptotic cell death 
Apoptosis is a form of energy-dependent cell death . The B cell lymphoma-2 (Bcl -
2) and caspase families of proteins are major families o!' proteins executing apoptos is. 
Apoptosis proceeds by acti vating pro-apoptoti c Bcl-2 family proteins in response to 
I I 
cellular stress - this triggers caspase activation and cleavage of multiple substrates 
required for cell surv iva l. Within the Bcl-2 family, proteins share conserved Bcl-2 
homology (BH) domains. This family of pro teins consists of two classes: the ant i-
apoptotic proteins and the pro-apoptotic proteins. Of the pro-apoptotic proteins, two 
subclasses exist: the etfector proteins which have BH domains 1-3 , and the Bl-13-only 
proteins. The anti-apoptotic proteins are identified by BH domains 1-4 (Chipuk et a!. 
20 l 0; Ulukaya eta!. , 20 11 ). 
The role of the pro-apoptotic effector proteins, Bak and Bax, are to induce 
apoptosis by opening a large channel in the outer mitochondri al membrane. Bak and Bax 
form o ligomers while embedded in the outer mitochondrial membrane. opening channels 
which al low proteins to exi t the mitochondrial intermembrane space (Youle & Strasser, 
2008). The Bl-13-onl y proteins recruit pro-apoptotic effector proteins and facil itate 
o ligomerization. They act as mediators for cellular stress responses, and relay these 
s ignals to the pro-apoptotic effectors. Anti -apoptotic proteins act to sequester BH3-on ly 
proteins from promoting apoptosis (Chipuk et al.. 20 I 0). These proteins (wi th the 
exception of A 1) have a C-terminal transmembrane domain, anchoring them to the outer-
mitochondrial membrane, where they can associate with and inhibit Bax/Bak or the BH3-
only proteins (Youle & Strasser, 2008). 
Apoptosis is ulti mately triggered by the Bcl-2 fam il y of proteins, but a complex 
s ignalling cascade links the Bcl-2 family to destruction of the cel l. The intrinsic and 
extrins ic apoptotic pathways end with activati on of caspases cystei ne proteascs whi ch 
cleave a diverse range of substrate proteins after an aspart ic ac id residue (U lukaya ct al.. 
20 11 ). The intrinsic pathway ofapoptosis is a cellular signalling pathway downstream 
from Bax/Bak's initi ation of apoptosis (Fig 1.3 ). After Bak!Bax homo-oligomers form 
pores within the outer mitochondrial membrane, the signaling cascade begins. 
Cytochrome C release induces formation of the apoptosome, a protein complex 
consisting of seven cytochrome C/Apoptotic protease-activating factor-! (i\PAF- 1) 
dimers. APAF- 1 activates caspase-9, which then activates caspases-3 and/or -7, which 
c leave a wide range of substrates resulting in cell death (Taylor et al. , 2008; Youle & 
Strasser, 2008). Apoptosis can be detected by analyzing the downstream effects of 
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Figure 1.3 : The intrinsic pathway of apoptosis. Anti-apoptotic proteins bind and inhibit 
BH3-only and pro-apoptotic proteins from initiating apoptosis. Prior to apoptosis, 
Bak/Bax oligomerize and insert into the outer-mitochondrial membrane. Pores formed by 
Bak/Bax allow cytochrome C release from the mitochondria, apoptosome fo rmation and 
widespread caspase activation. Adapted from Youle & Strasser (2008) . 
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multiple substrate cleavage. By cleaving cytoskelctal and cytoskeletal-a ociated 
proteins. the cell rounds and, wi thdraws its processes. This produces membrane blebbing 
which results in cell fragments ca lled apoptotic bodies. The nucleus is observed to 
condense and subsequentl y fragment. DNA is cleaved between histoncs, producing 
.. laddering .. of DNA on a gel - fragments of lengths in multiples of 200bp. Apoptotic 
bodies arc engulfed by neighbouring cel ls and macrophages. This is triggered by 
presentation of phosphatidylserine on the outer layer of the plasma membrane (normall y 
it is found only on the inner layer). Inflammation is assoc iated with necrotic cell death 
when cytoso lic proteins diffuse out of a dying cel l. Since apoptot ic bodies arc rapid ly 
engulfed by macrophages, inflammat ion is avoided (Taylor et al. , 2008). 
1.2.3 Preventing apoptosis after ischemic stroke 
Treatments arc in development to prevent apoptosis in the penumbra and some 
consist of delivering ant i-apoptotic Bcl-2 fam il y proteins to the injury site. Transfect ing 
SVZ PCs v ith Bcl-2 before middle cerebral artery occlusion (MCAO) results in 
increased numbers of Dcx neuroblasts and Tuj I+ immature neurons in the ischemic 
striatum, and reduced apoptotic acti ve caspase-3 I immature neurons (Zhang eta!., 2006). 
A fusio n protein consisting of a fragment ofTransactivator-of-transcription (TAT) protein 
from the lluman Immunodeficiency Virus and Bcl-xL (TAT-Bcl-xL), recovery can be 
attai ned in rodent stroke models (Doeppncr ct al. . 2009; Kilic et al. , 2002). A protein 
transduction domain ofT/\T is used. allowing the peptide to penetrate ce ll membranes. 
The intravenous application orTAT-Bcl-x L was shown to reduce inrarct size as well as 
apoptosis within the damaged striatum of mice fo llowing middle cerebral artery 
occlusion. Treatment improved motor runction lost after MCAO as assessed by rota-rod 
and elevated beam tests (Doeppner et al. , 2009). After TAT-Bcl-xL treatment, increased 
survival of striatal neurons (Kilic et a!., 2002) and increased surviva l of Dcx+ neuroblasts 
(Doeppner et al.. 2009) was observed, suggesting that functiona l recovery occurred. 
PC proliferation occurs in the SVZ after occlusion of the middle cerebral artery, 
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which produces an ischemic injury in rodents (Jin et al. , 200 l , Gordon et al., 2007). As 
well , after MCAO, Dcx+ ncuroblasts migrate Crom the SVZ to the peri-infarct cortex and 
differentiate into neurons and glia (Gordon et a l. , 2007; Zhang et al. , 2007). While 
treatment with TAT-Bcl-xL increases survival of migrating Dcx+ neuroblasts after 
M CAO (Doeppner et al. , 2009) it has not resulted in increased gliogenesis, as marked by 
NG2 immunohistochemistry. A treatment which preferentially increases new·ogenesis 
should stand to improve functional recovery. While protecting neurons in the penumbra is 
an exciting way to prevent long term disability, the latency to detect and treat stroke 
prevents treatment from be ing given in a timely manner. Harnessing the endogenous 
neurogenic response to CNS injury and using treatments to improve this response can 
expand the time window in w hich stroke can be treated. 
1.2.4 - Mcl-1 
Myelo id cell leukemia 1 (Mel-!) is an anti-apoptotic member o f the Bcl-2 family 
of proteins, classified based on its hi gh sequence homology to Bcl-2 (Kozopas et a!. 
1993). It has been shown to be a critical survival factor for embryonic PCs (Arbour et 
al. , 2008). In addition to using prote ins of the Bcl-2 fami ly to prevent penumbral 
apoptosis, Mcl-1 could be used therapeuticall y to protect NPCs during the endogenous 
neurogenic respo nse to injury (sec section 1.3). 
Mel-! mRNA is enriched within developing NPCs and immature neu rons in the 
developing telencephalo n (Arbour ct al. , 2008). Since Mel-! germl inc knockout resul ts in 
early embryonic letha lity (Rinkenberger et a!, 2000), an Mcl- 1 conditiona l knockout was 
made using Mcl-1 ( ti't) mice crossed w ith transgenic estin Cre mice. Nestin, an 
intermediate fi lament, is expressed within the NPC population. When Cre-mediated 
deletion of Mcl-1 occurred within embryonic PCs, 15-25% of Nest in+ cel ls died via 
apoptosis . Furthe rmore, significant numbers of Dcx+ ncuroblasts and Tuj I+ immature 
neurons initiated apoptosis when Mcl- l was knocked out (Arbo ur ct a l. , 2008). Mel- ! 
plays the same ro le in adult NPCs. Mel - ! is required for survival ofNPCs in the intact 
adult brain of Mcl-1 ( ti'l) mice, verified by electroporating the adult SVZ with a Nestin C re 
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plasmid and assessing levels of apoptosis . Mcl-1 gain-of-function in adult-derived NPC 
culture a lso reduced apoptosis (M alone et al. , 20 12). These results highli ght the role of 
Mel- I as a surv ival factor in neural stem and progenitor cell po pulati ons within the 
developing and adult bra in. ln compari son to Mcl-1 , other anti-apoptotic Bc l-2 family 
members such as Bcl-2 (Michaelidi s et al. , 1996) and Bcl-xL (Savitt et a l. , 2005) are 
required for survival of post-mito tic neurons. Specificall y, Bcl-2 knocko ut mice have 
been shown to have increased apoptosis o f sensory and sympathe ti c neurons, while Bcl-
xL conditi onal knockouts using a Tyrosine l !ydroxylasc Cre transgenic mouse result in 
30% fewer catecho laminergic cell s in the substanti a ni gra. Together. these results show 
that Mcl-1 has an endogenous ro le in promoting survival in NPCs. A fter C S injury, a 
neurogenic response occurs whereby N PCs from the SVZ migrate and di fferentiate in the 
peri-infarct ti ssue, tho ugh most N PCs die when reaching the site of inj ury (Arvidsson et 
a l, 2002). Promoting survival by transfecting PCs with Mc l-1 could improve their 
viability in the ischemic penumbra and allow newborn neurons to integrate into local 
c ircui ts. 
1.3 - Stroke induced neurogenesis 
!\variety o f insults to the telencephalon can induce N PCs within the SVZ and 
SGZ to pro life rate . Moreover cells within the SYZ have been shown to migrate toward 
the site of injury and differentiate into mature neurons and glia. Exploiting the injury 
response in the CNS is an attracti ve strategy to repa ir the CNS after damage. 
1.3. 1 - Neura l precursor ce lls proliferate after CN S injury 
PCs in the CNS proliferate in response to injury. T hi s was demonstrated after 
cortical aspiration lesions in rats, where an increase in PSA-NCAM+ cells in the 
ipsilateral SVZ was observed post-aspiration (Sze le & Chcssclct, 1996). Since then, a 
host oC studies have dem onstrated an increase in SVZ proliferatio n under a variety of 
conditions (Gord on et a l. , 2007; Jin et a!. , 200 1; Kreuzbcrg et a l. , 20 I 0; Liu et al, 1998 ; 
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Tonchev eta!, 2003: Wang eta!. , 2007b; Zhang et a!, 200 l ). Quinolinic acid (an MDA 
agonist) used in a model of glutamate exc itotox icity induces SVZ proliferation in striatal 
lesions up to one day post lesion in rats (Gordon et al. , 2007). MCAO which is widely 
used in rodents also induces NPC proliferation. Prol iferat ion after MCAO increased SGZ 
& SVZ proliiCration in gerbils (Liu et al.. 1998) and rats (.lin et al., 2001. Zhang et al.. 
200 I) . The response in the rat revea led a doubl ing of the number of Dcx I neuroblasts in 
the ipsilateral VZ 14d after MCAO (Zhang et al., 2004). A proliferative response was 
also observed in the macaque after global ischemia (Tonchev et al. , 2003 , (Tonchev et al, 
2005). Similarly, an bT- l mediated cortical ischemic injury produced an increase in 
ipsilateral SVZ proliferation in the mouse (Wang et al. , 2007b). These results show that 
PCs respond to C S damage by proliferating. and that thi s response is conserved in 
several mammalian species. This e!Tect is noteworthy in the injured brain in that PCs 
can migrate away from the SVZ, move into damaged tissue and differentiate into cells of 
the neural lineage. 
1.3.2 eural precursor cells mi grate away from the SVZ and differentiate after CNS 
InJury 
In addition to proliferation. PCs have been shown to migrate toward damaged C S 
tissue. Early studies produced ev idence for neurogenesis following ischemia, but did not 
demonstrate the origin of the newborn neurons. eurogenesis was demonstrated by BrdU 
administration post thrombotic-stroke in rats, as cell s co-labeled for 13rd I and euN I 
(a mature neuronal marker) were observed in the lesioned cortex I 00 days post-
photothrombolytie ischemia (Gu et al.. 2000) and post-MCJ\0 (.Jiang et a l. 200 I ). Soon 
after, studies using MCAO in the rat demonstrated Brd + euN I cells in the injured 
striatum as well (Arvidsson et al. , 2002, Parent et al, 2002). Moreover, adjacent to the 
SVZ, chains of Dcx 1-/BrdU+ neuroblasts ex tended into the striatum toward the damaged 
ti ssue. suggesting that the newborn neurons were of SVZ origin (/\ rvidsson et al. , 2002). 
The peak number of migrating neuroblasts occurs 7- 14 days post-MC/\0 (Zhang et al. , 
2004). suggesting that thi s neurogenic response occurs rapidly. soon after ischemia. The 
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neuroblasts which migrated toward the cortex post-MCAO were found to be between 1.5-
2.5% o f the BrdU+ cells w ithin the peri-infarct ti ssue with the majori ty of BrdU+ cell s 
fo und to be microglia (Kreuzberg et at. , 20 1 0). These neuroblasts were traced using 
transgenic mice expressing EGFP under the 5HT3A promoter (5 -HT receptor 3A, 
expressed by a subset of SVZ neuroblasts and GABAergic interneurons) to mark 
neuroblasts. BrdU was used to identify newborn EGFP+ neuroblasts. Using the 5HT3A-
EGFP mouse, MCAO resulted in EGFP+/NeuN+/BrdU+ neurons in the ischemic cortex. 
demonstrating that cortical/striatal neurogenesis post-ischemia was SVZ-derived. The 
source of migrating NPCs was revealed using retroviral vectors to insert the GFP gene 
into PCs in the SVZ (Goings et a t. , 2004, Gordon et a t. , 2007). By labeli ng SVZ NPCs 
with a fluorescent marker such as GFP, the source of GFP+ cells which have migrated 
can be said to have origi nated from the SVZ. Recently, studies have demonstrated some 
causes of neuroblast migration: factors released during angiogenesis, notably stromal-
derived factor-] (S DF-1 ) and /\ngiopoietin-1 , attrac t neuroblasts which express their 
cognate receptors (Ohab et at, 2006). These findings demonstrate that SVZ-derived PCs 
are the cells migrating and differentiating in the peri-infarct tissue, that N PCs are rapid ly 
mobilized for a short pe riod of time, and that migration is mediated by chemotaxic 
factors released during peri-infarct angiogenesis. 
Exploiting the migratory response for therapy was shown to be time-sensitive, as 
neuroblasts diffe rentiate into glia more often at later time points. The fate of SVZ 
progeny can be traced by injecting retroviruses carrying the GFP gene into the SVZ. 
Neuroblasts can then be located after mi grating away from the SVZ if they are GFP-1. In 
a model of quinolinic acid-induced cell death in the striatum, SVZ cells were observed to 
migrate toward the injury. At five days post-SVZ infection wi th retrov irus, the location of 
GF P+ cell s was analyzed (Gordon et at. , 2007). When the SVZ was infected 2 days prior 
to injury or on the day of injury, the majority of migrating cells expressed GFP and Dcx 
(indicating neuroblasts migrating from the SVZ). In contrast, an infection 2 days post-
lesion resulted in 99% of GFP - cells being Dcx- and having a g lial morpho logy (Gordon 
et a!. , 2007). Thi s demonstrates that neurons are produced in a time-sensitive manner 
after injury and therapies de livered immediately after ischemia may have the greatest 
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impact on neurogenesis. 
1.3.3 - The majority of neural precursor cell s die when migrating toward a CNS injury 
Despite the ability of PCs to migrate toward the injured cortex and striatum. the 
fract ion of cells wh ich urvive to maturity is low. Following MC/\0 in rats. Dcx I cel ls 
were monitored in the i chemic striatum. There were approximately 4000 Dcx /Brd 
cells in the ischemic stri atum 2 weeks post-MCAO. whereas. at 6 weeks post-MCAO, the 
number ofNcuN I / Brd U 1- neurons was approx imately 800. Thus, in the ischemic 
stri atum, 80% of migrating neuroblasts do not become mature neurons (Arvidsson et al. , 
2002). These results highlight a challenge toward using PCs therapeutically to improve 
post-stroke recovery: how to prevent the death of neuroblasts and newborn neurons. Of 
the surviving mature neurons. half of the eu 1 /BrdU·I cel ls expressed D/\ RPP32. a 
marker for mature striatal medium spiny neurons. This demonstrates that SVZ IPCs 
have the ability to differentiate into area-specific subtypes - therefore urging NPCs to 
differen tiate into a desired subtype may be an avoidable hurdle to therapy. However, 
since the ast majority of cel ls do not become mature neurons. therapy with pro-surviva l 
proteins could dramatically boost the number of mature neurons post-stroke. 
lnOammation has been linked to high levels of migrating neuroblast apoptosis 
post-injury. Mice depleted ofCD4 1 T-lymphocytes (lymphocytes involved in 
inflammatory cytokinc release and macrophage activation) were studied a fter MCAO. 
1\poptosis was reduced by 50% in ncuroblasts migrating toward the infarct boundary 
(Saino et al. , 20 I 0). This reveals that the environment ncar the si te of injury promotes 
neuroblast death and further re eals the need to r anti-apoptotic therapies for post-stroke 
PC survival. 
Treatments invo lving Bcl-2 overexpression in NPCs have decreased apoptosis in 
the hippocampus post-MCAO (Sasaki et al. , 2006). Overexprcssion of Bcl-2 fami ly 
members may. therefore, reduce apoptosis in SVZ-dcri ved PCs. We have previously 
shown that Mel- ! is a critical survival l~1c tor for adu lt PCs in the SVZ (Malone et al. . 
20 12). Type B. C and!\ ce ll s wi thin the SV/. express Mel-!. When PCs were 
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transfected with Cre in an Mel- I f1oxed mouse, the rate of PC apoptosis was increase I 
two-fold. As well , when cultured PCs ovcrcxprcsscd Mel- I, apoptosis decreased three-
fol d. These data suggest that Mel- I is a crucial survival factor for NPCs, and may be 
useful in increasing their survivability. Therefore, ovcrexpressing Mel- I in the SVZ after 
cortical injury has the potential for increa ed regeneration or neurons. as migrating 
neuroblasts and immature neurons are otherwise vulnerable to apoptosis. 
1.3.4 - Gene deli very to the SVZ has therapeutic potential 
Regeneration of cortical tissue can be studied by observi ng ncurogcncsis and 
gliogenesis in the peri-infarct cortex or striatum . Since many neuroblasts leaving the SVl 
die before they become mature neurons, therapies that improve their surviva l are 
warranted. One method that can be used is gene therapy: introducing pro-survival genes 
into NPCs before or during their migration toward the peri-infarct cortex . Improving 
NPC surviva l via gene therapy is an attracti ve method to regenerate more neurons post-
ischemia. In order to introduce gene into NPCs, the lateral ventricle wall can be targeted. 
These PCs may integrate successfully into existing circuits. translating into measurable 
behavioural rcco cry on fore limb motor control tasks. which is the ultimate goal of 
regenerati vc therapy. 
Gene deli very targeting type B cells can be performed via in vivo clcctroporat ion. 
This process involves injecting plasmid DNA into the lateral ventricle and administering 
an electric pulse across the head (Fig. 1.4). Wh ile 95% of cell s translcctcd are ependymal 
ce ll s (Barnabe-ll eidcr ct al. , 2008). a minority ol'transfected cell s arc type B ce lls vvhich 
make contacts wi th the ventricle. After passing genes on to type C and t pe !\cell 
progeny, the efficacy o r exogenous genes in improving type!\ cell (neuroblast) viability 
can be assessed. Previously our laboratory (the Vanderl uit laboratory) ha used adult 
electroporation to knock out Mcl- l in the adult PC population. Us ing plasmid D A 
containing Cre expressed under the cstin promoter, the plasmid was elcctroporated into 
the SVZ in an Mcl- 1 (Ill) mouse where Cre c, pression was observed in PCs (Malone et 
a!.. 20 12). As genes expressed under the est in promoter will only be expressed in the 
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NPCs, and not the ependymal cells lining the ventricle. thi s demonstrates that adul t 
electroporation can deli ver genes to NPCs. Using this technique to trace neuroblasts 
migrating from the SVZ toward the injury site would demonstrate that neuroblast gene 
therapy is possible post CNS injury. Furthermore, our laboratory has shown that 
transfection of Mcl- 1 into NPCs in vitro increases their survival 3-fold (Malone et al. , 
20 12). This work sets the precedent that Mel- ! overexpression in PCs can increase 
survival and that it can be reliably introduced into type B cell s in vivo . Using an ischemic 
cortical injury model to induce NPC prol iferation and migration, the eiiects of Mcl-1 on 
NPC survival after migrating into infarcted tissue can be assessed. However, to assess 
Mcl-1 's effect on functional stroke recovery, a cortical injury model with relevant 
behavioural assessments must first be selected . 
1.4 Appropriate models of CNS injury & repair in mice 
1.4. 1 - Models of focal cerebral ischemia 
In selecting a model of focal ischemic injury, three cri teri a should be met: (I), that 
a small reproducible ischemic inj ury can be produced; (2), that the injury correlates wi th 
relevant reproducible behavioural deficits ; and (3), that the neural precursor population is 
not damaged during the inj ury. as they are required to regenerate injured neural tissue. 
While ischemic injury models available today have a variety of pros and cons. the 
objecti ve is to choose a model best suited for regeneration of damaged cortex in the 
mouse. Of the models of focal ischemic injury avai lable. three of the most widely used 
mode ls arc MC AO. photothrombotic ischemic injury, and ET-1 induced ischemic inj ury. 
MC/\0 is a technique which involves occluding the middle cerebral artery -
usually with nylon thread of a specifi c diameter. This thread is inserted into the common 
carotid artery. and pushed through the internal carotid artery until it occludes the middle 
cerebral artery. The thread can be withdrawn at any time, depending on the size and 
extent of ischemic injury desired (Engel eta!. , 20 11 ). As the volume of brain supplied by 
the midd le cerebral artery is quite large, encompassing much of the striatum and 
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Figure 1.4 Electroporation of the Ad ult Subventricular Zone - P lasm id DN/\ is injected 
into the lateral ventricle (black) as depicted by the needle track (blue hashed li ne). 
Electrodes are placed o n either side of the head, with the posi tive electrode on the side of 
injection. An e lectric pul se (orange arrows) forces DNA into cel ls on the late ral side of 
the ventric le which express a fluorescent protein marker (depicted in green). 
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overlying cortex, the size of the injury tends to be large as we ll. Add itionall y, backtlow 
via leptomeningeal collateral arterioles into the middle cerebral artery territory can 
reduce ischemic damage. The leptomeningeal collateral network is variable between 
animals and can produce unwanted variability. Additionally, mouse strains with more 
collaterals are more resistant to MCAO induced ischemic injury (Zhang et al., 201 0). 
Photothrombotic ischemic injury is an injury whereby a systemic photosensitive 
dye (rose-bengal) is stimulated to produce molecular oxygen, which stimulates fi brin clot 
form ation (Watson et a l. , 1985). The dye is acti vated by illuminating the cortex with arc-
lamps filtered to 560nm light, or a laser, which can target a precise region of the cortex 
based on where it is shone. While this model is precise and can produce small targeted 
infarcts, there is significant overhead cost invo lved with purchasing laser equi pment and 
dyes. 
ET- 1 ischemic injury involves injecting ET-1 , a vasoconstricti ve peptide, into a 
desired location where it produces an ischemic inj ury by occluding local vascu lature. ET-
1 produces a small precise injury, given the overhead costs of a stereotax ic surgery 
apparatus and the peptide itse lf. The surgical equipment for ET-1 injections alone is more 
cost-effecti ve than equipment required for phototlu·ombotic ischemic injury as it obviates 
the need of expensive laser equipment. 
Table 1.2: Comparing ischemic injury models 
Injury Type MCAO Photothrombosis ET-1 
Cost Low High Low 
Infarct Size Large Small & prec ise Small & precise 
striatal/cortical 
From Table 1.2, the benefits of using ET- 1 ischemic injury for a model of cortical 
ischemia arc clear. It produces a small targeted infarct, which makes damage to the PCs 
avoidable. Producing a small infarct may fac ilitate more complete regeneration of the 
infarct. As well , the overhead costs are lower than those associated with photothrombotic 
inj ury. As stereotax ic surgery is a widely popular technique, the apparatus required for 
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E'T'- 1 ischemic injury may already be available in local research facilities . 
As there is a great reservoir of transgenic mouse strai ns, as opposed to rats, there 
are many regenerati ve therapies that would only be possible to test in these mouse strai ns. 
However, there are very little data comparing behav ioural tests to small cortical ischemic 
injuries in the mouse. A variety of research projects can take advantage of a model of ET-
1 induced cortical ischemia in the mouse, where behavioural tests can be used to predict 
the injury. While ET-1 requires study in its role in mouse cortical ischemic injury models, 
its pharmaco logical properties have been studied extensively .. strongly supporting its use 
in a model of ischemic stroke. 
1.4.2 - ET-1 induced cortical ischemia 
ET-1 is a 2 1 amino acid, soluble, vasoactive peptide which can produce ischemic 
CNS lesions. Endogenously deri ved from vascular endothelial cells throughout the body, 
ET- 1 is a mediator o f smooth muscle tone in the vasculature. ET- 1 acts on smooth muscle 
and endothelial cell s adjacent to where it is re leased (Davenport.. 2002). 
ET-1 can act as a vasoconstrictor or a vasodilator, based on which receptor 
subtypes it interacts with. Endothelin-receptor subtype A (ET-A) is fo und on smooth 
muscle and induces it to contract - inducing vasoconstriction. In contrast.. endothelin-
receptor subtype 8 (ET- B) is found on endotheli al cells and activates nitric oxide 
synthase resulting in nitri c ox ide release (Davenport, 2002). Nitri c oxide diffuses through 
ce ll membranes and acti vates guanylate cyclase in smooth muscle cell s (Derbyshire & 
Marietta, 2009). Guanylate cyclase produces cyclic GMP, signals myosin light chain 
kinase dephosphorylation in smooth muscle and .. subsequently, prevents smooth muscle 
contraction (Surks, 2007). While ET- 1 can have opposing effects on the vasculature in 
the brain, vasoconstri ction is the net response when appl ied exogenously. 
Local application of ET-1 in vivo can produce vasoconstriction lasting long 
enough to induce ischemic ti ssue damage. In particular, ET- 1 can be used to induce an 
ischemic lesion in the CNS. In rats .. this has been demonstrated by injecting ET- 1 intra-
striatally (fuxe et al... 1992) and intra-cortically (Windle et al. , 2006). Similarl y, in the 
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mouse, ET- l can induce an ischemic lesion by intra-cortical inj ection or by injection into 
subcorti cal white matter (Sozmen et al , 2009 ~ Tennant ct al., 2009~ Wang et al. , 2007b). 
However, these injections produce small lesions local to the site of injection. and are 
much smaller in size than ET-1 induced lesions in rats (Windle et al. , 2006). 
The size of ET-1 induced lesions in mice may be due to the profile of ET-1 
receptors in the mouse brain. The degree to which the cortical vasculature responds to 
ET-1 is related to the ratio of ET-A to ET-B receptors. In mice, the ET-A:ET-B ratio is 
lower than in rats (Wiley & Davenport, 2004) and may therefore account for smal ler 
infarct sizes in mice. As ET-B receptor acti vation leads to ni tri c ox ide synthase activation, 
L-NAME. a nitric oxide synthase inhibitor, has been shown to increase lesion size and 
behavioural defici ts on a forelimb motor task in mice when co-injected wi th ET-1 in the 
cortex (llorie et al. , 2008). This demonstrates the role that ET-B receptors play in 
mitigating ET- 1 mediated ischemic injury. I~lori e and col leagues initially found no infarcts 
using intra-striatal ET-l injections, but found infarcts when ET-1 was co-injected wi th L-
NAME. The reason that no in farcts were initially discovered may have been due to their 
sectioning protocol: they used 2mm thick sections instead of20 & 50f1m thick sections in 
which small ET-1 mediated infarc ts are easil y distingui shed (Wang et al. , 2007b, Tennant 
et al. , 2009, Sozmen et al. , 2009). This suggests that an infarc t may have been produced 
but the thickness of the sections was inappropriate to analyze the infarct. Despite the size 
of ET-1 mediated infarcts being smaller than those in rats, they do occur and there arc 
multiple studies demonstrating consistent injuries in mice (Wang et al. , 2007b, Tennant et 
al. , 2009, SoZJncn et al. , 2009). ET-1 is, therefore, a useful too l to produce ischemic 
injury in the mouse cortex, white matter and striatum, reliably producing a small focal 
lllJ ury. 
!\major limitati on of previous studies usi ng I ~T-1 to target the mouse forelimb 
motor cortex (FMC) is that the FMC was not previously mapped in detail. The standard 
map for the mouse motor cortex has been the Mouse Brain Atlas (Franklin & Paxinos, 
2004) which uses rat cortical motor maps to infer the location of the mouse motor cortex 
(Zilles, 1985, Fig. 1.5, red shaded area). However. recently the mouse FMC has been 
specifically mapped. This was done by stimulating the cortex in a grid pattern using 
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micro-e lectrodes and o bserving the corresponding motor response (Tennant e t a l. , 20 11, 
Fig. 1.5, green shaded area). The core of the FMC includes an area of cortex where 
stimulation e lic its a forelimb response 80%-100% ofthe time (Fig. 1.5, dark green 
shaded area). Outside this area, stimulation elicits fore lim b motor responses less than 
80% of the time - at the edge of the FMC, stimulation elici ts a fore lim b response less 
than 20% of the time. Because the ET-1 induced ischemic lesion is so small in the mouse 
cortex, studies which did no t directly target the core of the FMC with ET-1 injections 
may have seen poor or no behavioural deficits. Behavioural tests, such as the Rota-rod 
and horizontal ladder have traditionally been used to assess changes in gai t, but have 
been shown to predict FMC injury in mice (Farr et a l.. 2006). 1\s Wang & co ll eagues' 
(2007) injections were anteri o r to the fore lim b region, it is understandable that they saw 
on ly a transient impairment on the Rota-rod test at 1 h post-surgery which did not persist 
at 3 days post-surgery. As well , Tennant & colleagues (2009) saw meagre impairments on 
behavio ural tests: mice tested on the horizontal ladder only had deficits up to 2 days post-
surgery, which resolved thereafter; cy linder tests (d isc ussed in section 5.2) showed no 
deJicits at a ll . By attempting to ablate the core or the FMC wi th an ET-1 induced 
ischemic lesion using the recentl y available map, development of an injury model with 
less variability and more robust behavioural deficits may be possible, in contrast to 
previous studies. 
1.4.3 Behavioural testing in mouse models o f cerebral ischemia 
Research into how behavioural scores correlate to ET- 1 mediated ischemic injury 
is valuable - predicting cortical injury can allow better assessment of the extent of injury 
and the extent of functional recovery aft er therapy. When targeting the FMC wi th an 
ischem ic injury, onl y behavioural tests pertinent to the region of injury should be used. 
The cylinder test of fore ! imb asymmetry and the mouse staircase test are two tests o f 
forelimb motor function which are currentl y employed in mouse mode ls o f ET- 1 
mediated ischemic injury in the cortex. 
The cy linder test (Scha ll ert et al, 2000) of fore limb asymmetry is a measure of 
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Figure 1.5 - Motor maps of the adult mouse brain. Overlaid on a transverse view of the 
adult mouse brain are two maps. The positive end of the vertical ax is represents the 
anterior end of the brain. The motor map according to Frankl in & Pax inos (2004) is 
depicted in red hashed lines. The forel imb motor map according to Tennant ct a! (20 11) is 
depicted in light and dark green hashed lines. The I ight green area represents the FMC 
whereby >5% or more of cortical electrode stimulations resul ted in fo relimb motor 
movement. The dark green area represents the FMC whereby 80- l 00% of cortical 
electrode stimulation resulted in fo relimb motor movement. 
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gross forelimb motor contro l which has recentl y been adapted for use in mice (Baskin et 
al. , 2003 ). Mice use their forelimbs to support themselves while rearing: such supportive 
movements do not require dextrous reaching but do req uire coordinated use of their 
fo repaws and limbs. Mice explore a translucent cy linder by rearing against the wall s (Fig 
2.2); the proportion of left vs right paw contacts is then quantified. ln the event of 
unilatera l FMC injury, a deficit in paw contacts contralateral to the injured hemisphere is 
observed. After MCAO, such deficits can be measured soon after injury (1-1 4 days post-
injection) but reso lve without treatment from 3 weeks post stroke onward (Schallcrt ct al.. 
2000). Similarly, Wi ndle & colleagues showed that defi cits on the cy linder test attenuated 
between l and 4 weeks post-MCAO in rats. Though ET- 1 induced cortical injury also 
presented a cy linder deficit at l week, a reduced but significant deficit was still present at 
4 weeks post-injury (Windle et al.. 2006). The cy linder test may. therefore, have 
predictive value in a model of ET-1 induced cortical injury in the mouse. even with long-
term assessments. 
The mouse staircase (Baird et a!. , 200 l ), adapted from the original rat staircase 
(Montoya et al. , 199 1), is a behavioural test examining fore limb motor function. This test 
specificall y analyzes fine motor skill s invo lved in reaching and grabbing with the 
forelimb in comparison to the cylinder test. Mice learn to reach pellets placed on 
staircases on either side of a central beam supporting the mouse (Fig 2. 1 ). Severity of 
torelimb motor cortical injury is associated with fewer pellets retri eved by the limb 
contralateral to the injury. This test has been shown to predict cortical injury wi th high 
accuracy fo llowing cortical aspiration injury in the mouse (Baird et al. , 200 I) and in the 
rat (Montoya et al, 199 1 ). Furthermore this test has predictive value for rat fo reli mb 
motor functi on after intra-cortical ET-1 induced ischemic injury (Windle et al. , 2006). 
Due to its success in pred icting corti cal injury, the staircase should be tested wi th ET- 1 
induced cortical injury in the mouse. 
These tests have been investigated and successfull y adapted for mice; 
furthermore, they are reliable predictors of injury to the FMC (Baird et al., 200 I , Baskin 
et al. , 2003). These tests will be used to predict ET- 1 induced FMC injury in the mouse. 
Using the same behavioural tests to observe reduction of deficits under treatment 
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conditions, regeneration o r damaged tissue and functional recovery may also be assessed. 
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Rati onale: 
ET-1 has been successfully used in mice to induce ischemic stroke damage to the 
cortex. Despite this, there are issues with the variability of injuries. with some studies 
reporting no injuries at all. Therefore. demonstrating that ET- 1 can produce consistent 
cortical infarcts is crucial to developing a model of focal ischemic injury in the mouse. 
Behavioural tests must then be calibrated so that behavioural deficits correlate with 
damage to a specific area of the cortex. Though mouse staircase and cylinder tests 
correlate with motor cortex inj ury in other models of CNS injury, they have not been 
tested in ET- 1 induced cortical infarcts, which should be done. f urthermore, though ET- 1 
has been shown to produce cortical ischemic inj ury in the mouse, the histological 
parameters concerning dimensions, depth, location and vol ume of injury have not been 
correlated with behavioural defi cits. I propose that assessing the mouse staircase and 
cylinder tests against hi stological parameters of ET-1 injury can further characterize the 
ET- 1 injury model in mice. This may allow construction of inclusionary cri teria fo r l'uture 
experiments. based on the mouse staircase and cylinder tests. 
Additionally, a lthough SYZ NPCs proli fe rate in response to an ET-1 induced 
cortical ischemic injury, it remains to be determined whether neuroblasts migrate toward 
a focal ischemic injury in the cerebral cortex (Wang ct al. , 2007b). By investigating the 
numbers and location of Dcx I ncuroblasts post ischemia. I will assess the ab ility of a 
focal ischemic lesion to induce neuroblast prolife ration and migration. 
Hypothesis 1: The staircase and cylinder tests of forelimb motor function can measure 
ET- 1 induced cortical ischemic inj ury. 
Aims : 
A) To demonstrate that ET- 1 can produce an injury in the mouse FMC. 
B) To investigate whether the mouse staircase and mouse cylinder tests correlate with ET-
1 injury in the FMC. 
C) To demonstrate that the location of the I~T- 1 inj ury correlates with the behavioural 
deficit. 
Hypothesis 2: ET- 1 induced cortical ischemic injury can induce proliCeration and 
migration ofNPCs in the ipsilateral SVZ to the injury. 
Aim: To demonstrate that PCs in the SVZ prol iCerate and migrate toward the site of ET-
1 injury in the mouse. 
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C hapter 2: Methods 
2 .1 -Mice 
Male FVBN mice were housed on a 12 hour inverted light-dark cycle, so that 
behaviour could be tested during the day. Mice were g iven standard rodent chow and 
water ad libitum . A ll experiments were approved by Memorial University of 
Newfoundland's Anima l Care E thics Committee according to the guidelines of the 
Canadian Co unci I on Animal Care . 
2.2 - Stereotaxic surgery 
ET-1 inj ections (Calbiochem, 05-23-3800) were performed on 2-4 month old mice 
using a mouse stereotaxic apparatus (Kopf, 3080 19R). Body temperature was maintained 
from beneath with a heating pad (Softheat, HP2 18- 12-3P). Isoflurane (Aerrane, Baxter 
02225875) was used to anaesthetize mice and was mixed with oxygen us ing an iso n urane 
vaporizer (Harvard Apparatus, 34047 1). Anaesthesia was induced using 5%v/v isoflurane 
in oxygen and m aintained usi ng 2%v/v isoflurane in oxygen. After mice were 
anaesthetized, the scalp was shaved and disinfected with iodine solution (Proviodine USP 
l 0%, ZK Rougier, 00 172944) . A scalp incision was made in the anterior-posterior axis 
a long the sk ull' s midline. A ll injections were performed unilaterally, based on staircase 
test performance (descri bed in section 2.3). 
A three-dimensional coordinate system was used to landmark the injection site: 
the dorsal-ventral ax is (DV), the med ial-lateral ax is (ML) and the anterior-posterior axis 
(AP). Coordinates were first measured at lambda and bregma and identical ML and DV 
coordi nates at each location ensured that the head was level. The injecti on site was 
measured in relation to bregma. A hole was then bored into the skul l over the injecti on 
s ite wi th an Ideal M icrodri ll (Cellpoint Scientific , 67- 1 000). A syri nge pump was used to 
contro l flow rate (Chem yx Fus ion 1 00). Injections were made using a 5 fll Hami lton 
syringe (7633-0 l) attached to polyether-ether-ketone tubing (Vici Valco Instruments) and 
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then to a coupler (Hamilton, 55752-0 I) to which a pulled glass needle (World Precision 
instruments, TW I OOF-4) was fastened. Stereotax ic coordinates, reagent concentrations. 
injection vo lume and injection rate Cor each type of injection arc detailed in Table 2. 1. 
During surgery, dehydration was prevented by administering 2m! of Lactated 
Ringer's so lution subcutaneously. Mice were given additional Lactated Ringer's so lution 
post-surgery if" body weight dropped below 80% of pre surgery weight or if mice 
presented dehydration-re lated behaviour. 
Buprcnorphinc (SOp!, 0.02mg/kg mouse weight) was also injected subcutaneously 
before mice were removed from anesthetic as a post-operative analgesic . 
Table 2. 1: ET- 1 stereotax ic injections 
Number Rate of Volume per 
of Injection injection 
injections (concentration) 
2 0 .2 ~LI /min I.O~LI (2.0 pghd) 
3 0.2~LI/min l .O).ll (2 .0 pg/).ll) 
Injection 
Location 
FMC 
FMC 
Coordinates (AP, ML, DV) 
Injection I : 0, + 1.50. -1.2 
Injection 2: 0. + 1.75, -1.2 
Injecti on I : +0.4, + 1.6, -1.2 
Injection 2: +0.2, + 1.35, -
1.2 
Injection 3: 0, + 1.75, -1 .2 
A daily dose of" bromodeoxyuridinc (Brd , Sigma, 85552, I OO~tg/g body weight) 
was administered intraperitoneally on post surgical days 4-8 to label pro li fe rating cells. 
2.3 - Mouse staircase test 
The mouse staircase is a test of sk illed forelimb reaching in mice (Campden 
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Figure 2.1 : The mo use staircase test. Mice enter the staircase cham ber (left) where they 
reach fo r food pe llets placed on the steps. There is a staircase on either side of a centra l 
beam preventing mice from reaching into the left staircase w ith thei r right paw (and vice 
versa). 
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Figure 2.1 
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Instruments, 80301 , F igure 2. 1 ). T he mouse performed the task by entering the staircase 
chamber and reaching fo r pellets on either side of a divider, separating the two staircases. 
Injury to the FMC (Endothelin-1 ) was associated with fewer pellets retrieved with the 
contralatera l fo re limb. 
Mice were given food rati ons as opposed to an ad libitum diet to motivate 
performance during training and testing. A dail y ration of 3g of standard rodent chow 
maintained the mouse's weight above 85% body weight. Ration size was increased to 4g 
if weight fell below 85%. The day prior to surgery, and unti l testing resumed, mice were 
fed od libitum. 
M ice were trai ned twice daily for a minimum of 7 days before surgery or until 
they retrieved a consistent number of pellets. Mice were trained to reach for 15 pellets 
( 14mg, Bio-Serv, F05684) per staircase, baiting the bottom five steps with three pellets 
each. T he top three steps were not baited, as mice retrieved pel lets from the top three 
steps with their tongue a lone. Reaching scores two days prior to surgery were used to 
evaluate whi ch hemisphere would be lesioned: the hemisphere contralateral to the paw 
which consistently reached the most pellets was chosen. In mice that d id not have a 
fo repaw preference but became proficient with both, in which case the hemisphere to be 
injected was chosen randomly. Mice were disqualified if they reached less than eight 
pellets per s ide or if the standard deviation was greater than I pellet four days before 
surgery. 
Mice were tested twice daily on 6,7, 13 and 14 days after surgery. The staircase 
contra latera l to the injury was baited with 15 pellets for testing, with the other staircase 
left empty. Data was only co llected for the paw contralateral to the injected hemisphere. 
Data from days 6 and 7 were averaged and analyzed as data from week I, whi le data 
from days 13 and 14 were averaged and ana lyzed as data from week 2. Data were 
recorded as number of pe llets retrieved per total pellets baited (15 pellets) and normalized 
to pre-stroke retrieval. 
2.4 - Mouse cylinder test and filming 
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This test exam ines gross forelimb motor deficits after FMC lesion and was used to 
gauge whether significant FMC injury had occurred. The test involved filming a mouse 
rearing and touching the side of a translucent cylinder (94mm diameter, Figure 2.2) wi th 
each paw. Mice performed without external motivation. 
The cylinder was placed on a translucent table and was filmed fi·om below fo r 
quantification. Animals were filmed for 5 minutes or until 20 touches occurred. The test 
was administered once per day on the day before surgery and 3, 7 and 14 clays post-
surgery. 
2.4.1 - Forelimb asymmetry analysis of the mouse cylinder test 
The test was quantified by anal zing each paw touch where the mouse's palm was 
11at against the side of the cyl inder. Touches quantified were counted as left-onl y, ri ght-
only or bilateral (any touch where both palms were in contact with the side of the 
cylinder). A shift from bilateral to unilateral touching suggested a unilateral motor cortex 
lesion. 
Forelimb asymmetry = total ipsilateral touches I (total ipsilateral touches total 
contralateral touches) 
2.4.2 - Paw-dragging analysis of the mouse cylinder test 
An alternate analysis of the cylinder test, regarding paw-dragging behaviour. was 
quantified by measuring how often the mouse dragged its paw against the cylinder wall 
during a rear. For a mouse to exhibit a paw-drag, the paw must make contact with the 
cylinder wa ll. Then, the mouse must drag its rorepaw mediall y and then wi thdraw it from 
the cylinder, all the while maintaining cylinder contact with the contralateral forepaw. A 
detailed demonstrati on of a paw-drag is depicted in Figure 3. 1 0. Data were expressed as 
the percentage of touches resulting in a drag per total number of touches with each paw 
and normalized to pre-stroke paw-dragging. For all regression analysis where mice arc 
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Figure 2.2: The mo use cylinder test of fore limb asymmetry. M ice rear against the sides of 
a translucent plexiglass cylinder w hi le they are filmed from beneath. 
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tested on the cylinder test, only data from the paw contra late ra l to the inj ection were 
analyzed . 
2 .5 - Perfusion and cryosectionin g 
Mice were euthanized with an intra-peritoneal injection of Euthanyl (sod ium 
pentobarbital, 240mg/ml , CDMV 032-C). Transcardia l perfusion was perfo rmed once the 
mouse was unresponsive. incisions were made to ex pose the heart , and the ri ght atrium 
was punctured to allow venous drainage. Ice cold l x phosphate buffered saline (PBS, 
137mM aC I, 27mM KCI, lOOmM Na2HP04, 18mM KH2P04, pH 7.4) ( l Oml) was 
injected into the left ventricle to flush c irculating blood, followed by 20 ml ice cold 4% 
parafo rmaldehyde (PFA, pH 7.4) as a fixative. fo llowing perfusion. the brain was 
removed from the skull and post-fixed in 4% PFA for 24h. 
Aft er post-fixati on, brains were cryoprotected in increasing concentrations of 
sucrose ( 12, 16, 22% w/v in I x PBS), then stored in 22% sucrose at 4°C unti I they were 
ready to be frozen . 
Brains were frozen in Tissue Tek O.C.T compound (Sakura Finetek, 25608-930) 
using 2-methylbutane on dry-ice, held at -80°C fo r at least 30 minutes then eq uilibrated to 
-24°C in the cryostat for 45 minutes prior to sectioning. Sections were collected at l4~tm 
thickness across a series of six slides (S uperfrost Plus, Fishcrbrand, 12-550-1 5), wi th 
three secti ons per s lide. Slides were stored at -80°C until used. 
2.6- Immunohi stochemistry 
Slides were warmed to 37°C for I 5 minutes and a hydrophobic moat was drawn 
aro und the tissue to reta in antibody solution (Dako Pen, Dako, S200230-2). For BrdU 
immunohistochemistry (IHC), slides were post-fixed in Acetone (Fisher Scientifi c, 
A94904) for one minute. S lides were then treated with 2N hydrochloric acid fo r 30 
minutes at 3 7°C to denature DNA, fo llowed by 0.1 M Sodium Borate (pH 8.0) fo r 10 
minutes. 
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Primary antibodies inc luded a-Doublecortin (for neuroblasts, 1:100, Santa Cruz 
Biotechnology, sc-8066), a-BrdU (1: 100, BD Biosciences 347580), a - euronal N uclei 
(for corti cal neurons, 1:500, Mil lipore, MAB-377) and a -Cux l (for layers II-IV cerebral 
cortical neuronal nuclei, I :500, Santa Cruz Biotechnology, sc-1 3024). Slides were 
incubated with a primary antibody overnight at room temperature. The following 
morning, slides were incubated for 1 h with the appropriate secondary antibody ( 1:200 
donkey anti-goat IgG (H+L) Alexa Fluor 488 - Invitrogen, A II 055 , 1:200 donkey anti-
mouse lgG (H+L) Alexa Fluor 594 - Invitrogen, A2 1203, 1:200 donkey anti-mouse lgG 
(H+L) Alexa Fluor 488- Invitrogen, A2 1202, and 1:200 donkey anti-rabbit IgG (I-I L) 
Alexa fluor 488 - Inv itrogen, A2 1206). Sl ides were cover-slipped in 1:3 glycerol: I x PBS 
and stored at -20°C. 
2.7- Immunohistochemistry imaging and counting 
Sections used in immunohi stochem istry were photographed using Zeiss 
Ax iovision v4.8 software with the Zeiss [mager.Z l (upright) microscope with l Ox and 
20x objectives, and a Zeiss Axiocam Mrm camera. lmageJ sof1ware 
(http: //rsbweb.nih .gov/ij/) was used fo r counting. Counts were expressed as total 
number of Dcx+ or BrdU+ cells adjacent to the ventricle or migrating toward infarcted 
ti ssue. Cell s were considered adjacent to the ventricle if they were within 25)-lm of the 
ventricular surface. Migration d istance was measured as the distance trave lled beyond 
thi s 25~tm contour of the ventric le. Six consecuti ve sections at 1 40~tm intervals were 
examined within the infarct o f each mo use. The average number of Dcx t- or BrdU cells 
per section was recorded. Experimenter was blinded to a ll experimental conditions. 
2.8- Cresyl v iolet sta in 
Slides were heated at 37°C on a slide warmer (Thermo Scientific, MH66 16Xl) fo r 
15min, then stained in 0 .2% cresyl v iolet (S igma, C l 79 1) for 30 minutes. T he sections 
were then dehydrated for 30 seconds each through a series of ethanols (50%, 70%, 90%, 
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95% and 1 oocvo (x3)) followed by isopropanol and toluene then cover s li pped wi th 
Entellan (VWR, 34 172- 1 02) and stored at room temperature. 
2.9 - Crcsyl violet imaging and in fa rct volume calculation 
Crcsyl violet stained slides were used to assess infa rct volume. Slides were 
photographed at 1.6x magni fication using Zeiss Axiovision v4.8 software with the Zeiss 
Stemi-2000 di ssecting microscope and a Zeiss Ax iocam Mrm camera. The olume of the 
infarct was assessed by measuring the cross-secti onal area of the in rarct on representative 
coronal sections, 1 40~tm apart, through the brain. I leal thy corti cal tissue was measured on 
either hemisphere using the outline tool, and then the infarcted area was calcu lated by 
subtracting the healthy cortical ti ssue area on the injured hemisphere from the uninj ured 
hemisphere. The infarct area of each section was multiplied by 1 40~tm to get an estimate 
of the in fa rct vo lume. The volume calculation fo r each section was added to get a total 
infarct volume for a specific animal. Volumes we re expressed as mm3. Experimenter was 
blinded to all ex perimental conditions. 
Infarct Volume = 140~Lm x 2.: (Healthy contralateral cortical area - Healthy ipsilateral 
cortica l area) 
2. 10- Depth mapping 
Depth maps were constructed using representative cresyl violet stained coronal 
sections. 1 40~tm apart, through the brain. The depth of injury extend ing fro m pia to the 
corpus callosum was measured in 250~Lm .. bins .. , throughout the medial-lateral extent of 
each secti on. An injury ex tending down to the corpus callosum was given a value of 
I 00%; otherwise depth was expressed as a percentage of damaged cortex. A 
1 40~mx250~Lm grid was overlaid on Tennant & co lleagues' map of the FMC. Overlap 
with the 80-100% core, 60- 100% core and the entire foreli mb motor area in general was 
calculated by noting which bins overlapped with each respective area of the F· MC. The c 
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values were recorded as percentages . 
2 .11 - Stati stics 
All statistics were perfo rmed using GraphPad Prism 5 software. Mice were tested 
on the staircase test tw ice daily with each time po int represent ing the average of four tests 
across two days ( 1 week staircase scores are the average of two tests on days 6 and 7, 
respecti vely) . 
In fa rct coverage of the FMC was compared to mouse staircase, cylinder and paw-
dragging behaviour with linear regression anal ysis to determine whether there was a 
correlation between the coverage of the FMC and defi cit severity. For each mouse, the 
number of orange and red co loured bins, representing deep cortical infarcts. were counted 
and ex pressed as a percentage o f the total number of bins in the 80- 100%, 60- 100% and 
40-100% regions of the FMC. For linear regression analysis, each mouse had a 
corresponding data po int at each time point tested on the staircase, cylinder and paw-
dragging tests respectively. 
To test whether the locati on of the infarct and the time post-surgery cou ld affect 
the severity of staircase defi c its, these variables were compared with a two-way repeated 
measures ana lys is of variance (ANOVA). Data from the mouse staircase were compared 
within time points (7 and 14 days post-surgery) and between gro ups (OFF-target saline, 
ON-target saline, 0 FF -target ET- 1, ON -target ET-1 ) using two-way AN OVA fo llowed by 
Bonferonni 's post-hoc analysis. Using data obtained from regression analysis com paring 
staircase deficits to infarct coverage of the anterior FMC, staircase data was separated 
into two groups - animals which had an inj ury which was '·ON-target" and those which 
had an injury which was ' ·OFF-target" . To separate the data , ET- 1 injected animals were 
identified as having an 0 -target infarct if at least 20% coverage of the anterior FMC4o-
100 was covered with orange or red bins. Those with less than 20% coverage were deemed 
OFF-target. To demonstrate that the location of injury from sal ine injections did not affect 
staircase de fic its , two criteria were made for being classified as ON-target: first that the 
majority of the injury fe ll within the anterior FMCw. 1oo and, if not, at least 30% coverage 
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of the FMC10-IOO with any depth of injury was required. 
To test whether the location of the in fa rct and the time post-surgery could alTecl 
the extent of forelimb asymmetry and paw-dragging, these variab les were compared with 
a two-way analysis o l' variance. Data from fo relimb asymmetry and paw-dragging 
analysis were compared within time po ints (before. 3, 7 and 14 days post-surgery) and 
bel\.veen groups (saline affected paw. saline unaffected paw, ET-1 affected paw. ET-1 
unaffected paw) using two-way repeated measures ANOVA fo llowed by Bonferonni 's 
post-hoc analy is. 
To determine whether there was a di fference in the number of Dcx t cells between 
the contralateral and ipsilateral SVZ to the in fa rct. Dcx+ cell counts were analyzed by an 
unpaired t-test. To determine the di fference in migrating Dcx cell s between the 
contralateral and ipsilateral corpus callosum and cortex to the infa rct. a two-way A OVA 
fo llowed by Bonferroni post hoc tests was used. Data were compared between 
hemispheres (contralateral vs ipsil ateral) and within max imum migration distances (up to 
1 50 ~tm , > I SO~tm - 300~m, ~300pm - 450~m or ~450~tm - 600~tm). Signifi cance was 
assessed at p<O.OS lo r all stati stical tests. 
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Chapter 3: Results 
3.1 - ET-1 induces ischemic injury in the mouse cerebral cortex 
To test whether ET-1 can create a reproducible infarct, ET-1 was injected twice into the 
FMC. During preliminary testing with FVB mice. I ~tg/~d concentrations of ET-1 
produced very small infarcts when injected intra-cortically (data not shown). Two 
injections were made using a relatively high concentration of ET-1 (2~tg/~l ) to ensure that 
the infarct was large enough to produce behavioural deficits. Cresyl violet stained 
sections obtained 2 weeks post-surgery were analyzed. Healthy ti ssue exhi bited large 
neuronal cell bodies easily resolved by the cresyl violet stain (Fig 3. 1A,B) (Lipton, 
1999). Mice receiv ing a saline injection had pale cresyl vio let stai ning ncar the surface 
and in the vicinity of the injection site. Sparse condensed cell bodies which appeared dark 
fi-om cresyl violet staining suggested mechanical damage from the needle puncture (Fig 
3. 1 C,D). In contrast, mice receiving ET-1 injections had broad infarcts often extending 
from the pia to the dorsum of the corpus callosum. The majori ty of the infarct was 
marked by an increase in small cell bodies, which stained darkly with cresyl vio let. The 
border of the infarct had pale cresyl violet stain ing with sparse condensed cell bodies. 
similar to that observed with mechanical damage in the saline injected mice (Fig 3.1 E,F). 
This demonstrates that two ET-1 injections produce a large ischemic injury in the mouse 
cerebral cortex which can be di stinguished by crcsyl violet histology. 
To quantify the size of the infarct, the volume was measured and compared to the 
damage observed in saline injected control mice. The mean volume of damaged tissue in 
saline injected mice was 0.42 ± 0.08mm3 In comparison, the mean volume of damaged 
ti ssue in ET- 1 injected mice was nearly three times larger at 1.43 ± 0.17mm3 (Fig 3. 1G). 
The ET- 1 induced infa rct volume is consistent with Tennant & colleagues' study 
demonstrating a mean vo lume near 1.0mm3 in mice (Tennant et al., 2009). The next set of 
mice was given three injections of sali ne or ET-1 to assess the effect of a larger injury 
size on behavioural defi cits. The mean volume of damaged tissue in saline injected mice 
was 0.34 ± 0.13mm3 compared to 2.55 ± 0.2 1 mm3 in ET- 1 injected mice - greater than 
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Figure 3. 1: ET-1 produces a s ignifi cant infarct volume in the mouse cerebral cortex. 
(A, C, E) Representative photomicrographs of cresyl violet stained brain sections from a 
control no-injection mouse, a saline injected mouse and an Endothelin-1 injected mouse 
respectively. 
(B, 0 , F) High magnification photomicrographs from A, C and E respective ly (black 
rectangles). 
G) Quantification or infa rct vo lumes between saline injected mice and ET-1 injected mice 
at 2 weeks post-injection, for two and three-injection groups. Data are expressed as mean 
± SEM (mice receiv ing 2 injections, n= 16 saline, n=25 ET-1 , mice receiving 3 injections 
n= 12 saline, n= 15 ET-1 , ***p<O.OOO l ). 
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the injury induced in the 2-injection group. Together these results suggest that ET-1 
produces an easily identifiable infarct in the mouse brain which is significantly larger 
than mechanical damage associated with a saline injection. 
3.2- ET- 1 infa rcts produce a deficit in the mouse stai rcase test when targeted to the FMC. 
Further tests were performed to determine if ET-1 induced infarct targeted to the motor 
cortex can produce measurable behavioural deficits. The mouse staircase test was used 
here to examine reaching and grasping motions with the fore limb. Mice were given two 
stereotaxic injections of ET-l in the motor cortex accord ing to the Paxinos motor cortex 
map (Fig 3.2A) (Franklin & Pax inos, 2004). Mice were tested on the staircase test before 
inj ection (which served as a baseline), at l week and at 2 weeks post-surgery. Of these 
mice tested, there was no trend toward a drop in pellet reachi ng (Fig 3 .2B). Due to the 
lack of an observed de ficit, a refined motor map specifically for FMC was required . The 
FMC map developed by Tennant & colleagues was used to select two new ET- l inj ection 
sites (Tennant et a!. , 20 11 ) . In contrast to the Paxinos map, the Tennant map is smaller 
and specifically represents forelimb motor function (Fig 3.2C). The core of the Tennant 
motor map represents a cortical area which, when stimulated w ith a m icroelectrode, 
induces a forelimb movement 80-100% of the time. Two injection sites were chosen 
within the 80-100% FMC core (dark green hatched area. Fig 3.2C) assum ing that the core 
of the FMC would be crucial to executing a fore limb motor movement. Mice with ET- 1 
inj ections within this area demonstrated a consi stent drop in pe llet reaching with the 
affected forepaw at I and 2 weeks post-injection, as opposed to mice which had 
inj ections based on the Pax inos motor map (Fig 3.2D). After performing a two-way 
ANOVA examining injection site locations versus the times which they were tested, there 
was a significant effect of injection sites on pellet retrieval (F(1.16)=23 .77, p<O.OO I, Fig. 
2E). Injection sites targeting the 80-100% FMC core were used in future experiments 
based on the ir abi lity to induce a consistent forelimb motor deficit. 
To increase the s ignal -to-noise ratio, future experiments used a smaller pellet size 
such that 15 pe llets (up from 10 pe llets) could be baited on the bottom 5 steps of the 
5 1 
Figure 3.2: ET-1 infarcts produce a deficit in the mouse staircase test when targeted to the 
FMC. 
A) The motor cortex according to Paxinos & colleagues is represented in the hatched red 
area on a hori zontal plane of the mouse brain (Franklin & Paxinos, 2004). The map is 
represented as a horizontal grid overlaid on the left cortical hemisphere, with both axes in 
reference to the skull landmark bregma. Injection coordinates were: a) AP+O.S, ML I 1. 75 
and b) AP+0.9, ML 1.75, A nterior-posterior (AP), Medial -lateral (ML). 
B) The graph represents the change in pellet reaching at I week and 2 weeks in reference 
to pre-stroke reaching, using injection coordinates in A. 
C) Injection sites were refined according to Tennant & colleagues' FMC map (Tennant et 
al. , 20 11 ) . The motor cortex is represented in the hatched green area on a horizontal plane 
of the mo use bra in, with the 80-100% core hatched in dark green. Paxinos' motor cortex 
map is included for comparison, in hatched red . Inj ection coordinates are: a) AP+O.O, 
ML+ l.S and b) AP+O.O, ML+ l.S . 
D) T he graph represents the change in pellet reaching at 1 week and 2 weeks in reference 
to pre-stroke reaching, using injection coordinates in C. 
E) Inj ection sites using Tennant 's map were compared to injection si tes using Pax inos· 
map. *** p<O.OO l 
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staircase (3 pellets per step, up from 2 pellets per step). The top three stairs o f the 
staircase were not baited due to mice retrieving pellets directly wi th their tongue. 
3.3 - T he mouse staircase test correlates with location and depth ofET-1 infarcts. 
After demonstrating that ET-1 can induce infarcts in the mouse cerebral cortex, ET-1 
induced injury was corre lated to behavioural deficits after assess ing mice using the 
mouse staircase test. Initial data comparing sta ircase reaching scores between ET-1 and 
saline injected mice were not significantly different (data not shown). In an effort to 
explain why some ET-1 injected mice did not have a staircase reaching deficit, the 
location of the injury was mapped according to Tennant & co lleagues' fore limb motor 
map. T he medial and late ral extremes of the infarct on representative coronal sections 
were mapped throughout the anterior-posterior extent of the infarct. This information was 
then overlaid on Tennant & colleagues' forelimb motor map using the Paxinos at las to 
reference anatomical features with an ante rior-posterior measurement. The percent of the 
80-100% FMC "core" (FMC80_100, and as per Te1mant et al, 20 11 ), that overlapped with 
the infarct map was recorded. Coverage ofthe core versus staircase reaching was 
analyzed in a regression analysis for mice receiving two injections of ET- 1 (Fig 3 .3A) or 
three injections of ET- 1 (Fig 3.38). No significant relationship ex isted between core 
coverage and sta ircase reaching data, however, a downward trend in reaching was 
observed with a greater percent of core coverage. 
Though location of infarct did not correlate wi th a stai rcase deficit, this co uld be a 
result of not taking into account information about the depth of infarct. Usi ng onl y 
information on the area of an infarct, a broad infarct would have the same value -
irrespective of whether it was shallow or deep. To test this, a depth map of the infarct was 
overla id on Tennant & colleagues' forelimb motor map. T he depth map was constructed 
by measuring the depth of infarct as a percentage of the di stance from pia to the corpus 
callosum at 250~Lm intervals from the midline of the brain (Fig 3.4A). A ho rizonta l grid 
was overlaid on top of Tennant & colleagues' FMC map, with bins of dimensions 140~Lm 
x 250~Lm. Bins were then shaded in one of five hues (blue, green, yellow, orange or red) 
54 
Figure 3.3 : The mouse staircase test compared to infarct location within the FMC. 
A) Regression analysis of infarct coverage of the targeted FMC80. 1oo core vs staircase data 
fo r mice receiving 2 injections of ET-1 at I week (R2 = 0.07223 , p = 0.2 150, slope=-
0.290) and 2 weeks (R2 = 0 .1 249, p = 0.098 1, slope=-0.434) (n=23) . 
B) Regression analysis of infarct coverage of the targeted FMCso-J oo core vs staircase data 
fo r mice receiving 3 injecti ons of ET-1 at 1 week (R2 = 0.007346, p = 0.7523 , slope=-
0.086) and 2 weeks (R2 = 0.0920 1, p = 0.2534, slope=-0.329) (n= 16). 
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based on the percentage of cortical depth which was inj ured. Each of the fi ve di fferent 
hues represented a further 20% of cortical damage (e.g. red represents 80-l 00% of the 
di stance from pia to the corpus callosum is damaged ti ssue). Saline injected mice had 
narrow and superficia l injuries, as evidenced by the lack of red bins (F ig 3.4B). In 
contrast, ET- 1 injected mice often had broad and deep inj uries encompassing most of the 
FMC core (fig 3.4C). 
To accurate ly determine which cortical layers were affected by inj uries of 
different depths, 11-IC was performed for Neuronal Nuclei ( eu ) (fig 3.5) which labels 
neuronal nucle i, and Cux I immunohistochemistry which labels neurons in cortical layers 
11-IV (fig 3 .5). These photos demonstrate that infarcts extend ing deeper than 40% of the 
cortex have damaged layers II-IV at those respective bins, but minimal damage to lower 
layer neurons was observed. Injuries extending from 60% of cortical depth and beyond 
(red and orange bins) will damage some layer V and VI neurons. Damage to layer V 
neurons may provide longer-term deficits clue to the fact that they project to spina l motor 
neurons. By ana lyz ing the percent o f the FMC covered by orange and red bins, 
correlations between staircase deficits and injury location may be improved . 
l-rom thi s point forward, data from mice receiving either 2 or 3 injections of ET-1 
were combined for regression analysis. By assum ing that coverage and depth of infarct 
spec ifical ly wi thin the FMC dictates de ficits and not overall vo lume of injury. the 
difference between the 2 and 3 injections groups is irrelevant w hen asking the question : 
docs greater coverage at greater depths corre late with behavioural de ficits? Examining 
only ET- 1 inj ected mice, a regression analys is was performed comparing the percent of 
infarct coverage o f the core descending to a minimum of 80% cortical depth versus 
staircase reaching (Fig. 3.6A). The re was no downward trend of stai rcase reaching 
observed as core infarct coverage increased at 2:80% cort ical depth. Th is suggested that 
damaging only the 80- 100% FMC core (FMCso- 1oo) is not sufficient for a lasting forelimb 
motor deficit. The regression analysis was then repeated, requi ring the 60- l 00% FMC 
(FMC60_100) to be covered by the infarct at 2:80% cortical depth (Fig 3.6B). A significant 
downward relationship in stai rcase reaching with greater core infa rct coverage was 
observed at both I and 2 weeks. By broadening the infarct depth requirement from 2:80 
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Figure 3.4 : Depth mapping of ET-1 infarcts. 
A) Depth maps were constructed by measuring the depth of cortical injury at 250~tm 
intervals lateral to the midline of representative 1 40 ~tm coronal brai n sections using 
Axiovision software. 
Depth maps were overla id on Tennant & co lleagues' FMC map. Each 140x250~tm '·bin" 
is coloured based on the depth recorded at that poi nt. 
B) Representative depth-map from a mouse with two saline injections. 
C) Representative depth-map from a mouse with two ET- 1 injections. 
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Figure 3.5: Cortical injury depth is associated with damage to specific cortical layers. 
Adj acent tissue sections ( 140~tm apart) were Nissl-stained, or stained using fluorescence 
immunohi stochemistry directed against NeuN or Cux I . Sections were taken from 
representati ve brains with representative cortical infarct depths of <40%, <60%, <80% 
and 80- 1 00%. The depth of injury and the depth of the cortex are shown on theN issl-
sta ined sections. 
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cortical depth to 2:60% cortical depth, the trend of lower staircase reaching at greater 
coverage of the FMC60_100 became more significant at one week (Fig 3.6C). When 
analyzing the 40-100% FMC (FMC40_1oo) at the same depth, the relationshi p was highly 
signifi cant at both time points and had a stronger correlation than comparisons in the 
FMC60_100 in each case (m=-0.835 at I week, m=-0.860 at 2 weeks, Fig 3.60 ). To 
examine whether the staircase test could correlate with the volume of T- 1 infarcts, a 
regression analysis was perfo rmed comparing int'arct volume with staircase reachi ng 
scores at I and 2 weeks post-surgery (Fig 3.6£). This analysis showed no significant 
linear re lationship between staircase test perfo rmance and volume of ET- l infarct. 
Likewise, correlations arc poor when comparing gross infarct coverage of the FMC with 
staircase test performance. This suggests that both the depth and location of the injury 
together are required to produce deficits in the stai rcase test. 
3.4 - The mouse staircase test specificall y correlates with infarcts in the anterior FMC. 
While data comparing staircase performance with infarct coverage of the FMC are 
highly significant, the FMC is nevertheless a heterogeneous region where neurons project 
to spinal motor neurons and then muscles, which are involved in many different fore limb 
tasks. ldentifying a location within the FMC which is crucial for staircase-related 
reaching and grasping motions may demonstrate a more significant behaviour vs 
coverage correlation. Recent work has demonstrated that two very large subdivisions of 
the FMC ex ist: an anterior region responsible for abductive movements, and a posterior 
region responsible for adducti ve movements (I Iarrison et al. , 20 12). The abd uction may 
be involved in the series of movements involved in retrieving pellets in the staircase test. 
To analyze whether in [arct coverage of the anterior FMC resul ted in sta ircase defici ts 
more o ften than similar coverage of the posteri or FMC, ET-1 injected mice were 
assessed in relation to percent infarct coverage of the FMCso-t oo, FMC6o-too, and FMC4o-
100 areas. Coverage was assessed separately for the portions of those maps which were 
anterior or posteri or (respectively) to the line AP -1 0.25 , which bisects the FMC into 
roughl y equal sized anterior and posterior sections. Correlati on of staircase performance 
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Figure 3.6: The mouse staircase test correlates with infarcts in the FMC. 
A) Regression analysis of% coverage of the FMCso-1oo at 2:.80% cortical depth of 
infarcted tissue vs staircase data for ET-1 injected mice at I week (R2 = 0.040, p = 0.222, 
slope=-0. 195) and at 2 weeks (R2 = 0.0 19, p = 0.398, slope-=-0. 14 7) (n=39). 
B) Regression analys is of % coverage of the FMC60_1oo at 2:.80% cortical depth of 
infarc ted tissue vs staircase data [or ET-1 injected mice at 1 week (R2 = 0. 184, p<O.O 1, 
slope=-0.588) and at 2 weeks (R2 = 0.139, p<0.05 , slope=-0.552) (n=39). 
C) Regression analysis of % coverage of the FMC60_100 at 2:.60% cortical depth of 
infarcted tissue vs staircase data for ET- 1 injected mice at I week (R2 = 0.1 29 
, p<0.05, slope=-0.466) and at 2 weeks (R2 = 0.181 , p<0.0 1, slope=-0 .598) (n=39). 
D) Regression analysis of% coverage of the FMC.w-Ioo at 2:.60% cortical depth of 
infarcted tissue vs stai rcase data for ET- 1 injected mice at 1 week (R2 = 0.232, p<O.O 1, 
slope=-0.835) and at 2 weeks (R2 = 0.210, p<O.Ol , slope=-0 .860) (n=39). 
E) Regression analys is of infarct volume vs staircase data for ET- 1 injected mice at I 
week (R2 = 0.057, p = 0.1425, s lope=-6 .912) and at 2 weeks (R2 = 0.006, p=0.630, 
slope=-2.487) (n=39). *p<0.05 , **p<O.OI 
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with infarct coverage of the anteri or FMC60_10o at 2:80% cortical depth demonstrated a 
remarkable signi ficance at 1 and 2 weeks post-injury (Fig 3.7 A). By analyzing FMC6o-1oo 
at 2:60% depth, the rel ationship was more signi (icant and the strength of the correlation 
improved (m=-0.682 at I week, m=-0.666 at 2 weeks, Fig 3.7C). /\na lyzing the FMC•o-100 
resul ted in a lower R~ than the analysis of the FMC60_100 at both time points, but a 
stronger slope at 2 weeks. (m=-0.566 at I week, m=-0.729 at 2 weeks, Fig 3.7E). This 
suggests that while the FMC60_100 is predominantly required for sta ircase ret rieval. the 
FMC-lo- 100 may contribute to staircase reaching behaviour as well. Consistent \·Vith our 
hypothesis, regressions of stai rcase retri eval with coverage of the posteri or FMC 
displayed no rel ationship whatsoever when analyzing the FMC6o-1oo at >80% depth (F ig 
3.78 ), 2:60% depth (Fig 3.70 ) and the FMC-10- IOO at 2:60% depth (Fig 3.7F). We 
concluded that damage in anterior as opposed to the posterior FMC results in greater 
defici ts in the staircase test. 
Using data obtained from regression analysis comparing staircase deficits to 
infarct coverage of the anterior FMC, the taircasc data was separated into two groups -
animals which had an injury which was "ON-target" and those which had an injury which 
was ·'OFF-target". To separate the data. ET- 1 injected animals were id ntified as having 
an 0 -target infarct if at least 20% coverage of the anterior FM C10-100 was covered wi th 
orange or red bins. Those with less than 20% coverage were deemed OFl ,.-target. To 
demonstrate that the location of inj ury from sa line injections did not a!Tect staircase 
deficits. two criteri a were made for be ing classi lied as ON-target: first that the majority ol' 
the injury fe ll within the anterior FMC10_100 and, if not, at least 30% coverage of the 
FMC-1o-1oo wi th any depth of injury was required. While the control groups (ET'-1 OFF-
target. sa line 0 -target, sal ine OFF-target) did not differ from one another in terms of 
staircase deficits, ET-1 on- target injections differed significantly Crom all control groups 
at 1 week, but not two weeks post-injecti on (Fig 3.8). 
3.5 - An alternate analysis of the mouse cylinder test correlates with locat ion and depth of 
ET-1 infarcts. 
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Figure 3.7: The mo use staircase test specifically correlates w ith infarcts in the anterior 
FMC. 
A) Regression ana lys is of coverage of the ante rior FMC60.100 at 2'.80% cortical depth o f 
infarcted tissue vs sta ircase data for ET-1 injected m ice at I week (R2=0.405. p<O.OO I. 
slope=-0.676) and at 2 weeks (R2=0.254, p=O.OO I. slope=-0.589) (n=39). 
B) Regression ana lys is o f coveragc of thc posterior FMC6o.1oo at 2'.80% cortical 
depth of infarcted tissue vs staircase data for ET-1 injected mice at I week (R2=0.0 15, 
p=0.456, slope=-0. 118) and at 2 weeks (R2=0.0 19, p=0 .398, s lope=-0.147) (n=39). 
C) Regression analys is o f coverage of the anterior FMC60.10o at 2'.60% cortica l depth of 
infarcted tissue vs sta ircase data fo r El -l inj ected mice at 1 week (R2=0.449, p<O.OO I. 
slopc=-0.682) and at 2 weeks (R2=0.360, p<O.OO I. slope=-0.666) (n= 39). 
D) Regression analysis of coverage of the posterior FMC60. 10o at 2'.60% cortical depth of 
infarcted tissue vs staircase data for ET- 1 injected mice at I week (R2=0 .004, p=O. 716, 
slope=-0.053) and at 2 weeks (R2=0.028, p=O.J il , s lope=-0 .1 6 1) (n=39). 
E) Regression ana lys is o f coverage o f the anterior PMC40.100 at 2'.60% cortical depth of 
infarcted ti ssue vs sta ircase data fo r T- 1 injected m ice at I week (R2=0.206, p<O.O I , 
slope=-0.566) and at 2 weeks (R2=0.278. p<O.OO I , s lope=-0.729) (n= 39). 
F) Regression analys is of coverage of the posterior FMC.Jo-1oo at 2'.60% cortical depth of 
infarcted ti ssue vs sta ircase data fo r ET- 1 injected mice at I week (R2=0 .000, p=0.990, 
slope=-0.002) and at 2 weeks (R2=0.001 , p=0.853, s lope=0.037) (n=39). **p<0 .01 , 
*** p<O.OO I . 
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1n addition to the mouse staircase test, the cylinder test of fore limb asymmetry 
was also used to corre late ET-1 induced ischemic injury. Thi s test has proved successful 
in predicting corti cal damage in rats (Schallert et a l. , 2000, Encarnacion et al. , 20 11, 
MacLellan et a!. , 2011 ) and in mice (Baskin et a!. , 2003) but has not been effective in 
predicting ischemic injuries induced by ET-1 in mice (Tennant et a l. , 2009). Overall , 
there was no diffe rence in use of the affected fo relimb between saline and ET-1 groups, 
using data from bo th 2 and 3 ET-1 injections (Fig 3.9A). Regressions analysis com paring 
fo re limb asymmetry with FMC core coverage were perfo rmed on mice with both two and 
three injections of ET-1. Regressions on e ither group alone showed no signi ficance (data 
not shown). There was no correlation between injury coverage of the FMC80_100 and a 
decrease in use of the affected paw (Fig 3 .9B). By examining cor coverage of the 
FMC6o-1oo using 2:_80% depth bins only, no trend or correlation was detected (Fig 3 .9C). 
Refining the data using 2:.60% depth bins did not result in a trend o r corre lation be tween 
core coverage and use ofthe affected fo repaw (Fig 3.90 ). From these data, an ET- 1 
induced ischemic injury to the FMC cannot be detected using the c lassical cylinder 
fo re limb asymmetry analysis. 
Therefore a new analysis fo r the mouse cy linder test was developed. After mice 
rear and touch the sides of the cylinder, they push off from the cy linder wa ll and land on 
their fo repaws. However, mice with ET-1 induced cortical ischemic inj ury tend to 
d ismount normally with their unaffected paw, but let their aJTected paw-drag against the 
side of the cylinde r toward the midline of their body as they withdraw it. Thi s behaviour, 
which wi ll be referred to as ·'paw-dragging" and is the basis fo r further cylinder analysis. 
Eight still frames of a video demonstrating '-paw-dragging" a re shown in Fig 3. 1 0 . A 
mouse wil l approach the cylinder wall (Fig 3.10A) and place one or both fo relimbs firml y 
against the s ide of the cylinder (Fig 3. 1 OB). When the mouse di smounts, it pushes against 
the s ide with both paws (F ig 3. 1 OC) and lowers its fo repaws to the ground (fig. 3. 1 00 ). 
In contrast, the injured mouse will initially make contact with both forepaws (Fig. 3. 10E), 
slightly withdraw the affected paw (Fig 3.1 OF) and drag the affected paw along the 
cylinder toward the midline of the ir body (Fig 3. 1 OG) before withdrawing it from the 
cy linder wall entire ly (Fig 3 .101-I) . 
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Figure 3.8: ON-target injections of ET- I produce significant stai rcase defic its. 
Analysis of staircase reaching data for saline and ET-1 injected groups, separated by 
whether the location of the inj ury was inside or outside the anterior FMC (n=7 saline 
OFF-target, n= l 8 saline ON-target, n= 12 ET- 1 OFF-target, n=26 ET-1 ON-target) . 
Frrcaum:nt(3 ,59)=4.71 , *p<0.05 
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Figure 3.9: Classical analysis of the mouse cylinder test does not correlate with ET-1 
infarcts. 
A) Analysis of cylinder forelimb asymmetry data fo r 2 and 3 cortical inj ections. N=20 
Saline, n=35 Endothelin- 1. 
B) Regression analysis of coverage of the 80- 100% FMC core with infarcted tissue vs 
cylinder data for ET-1 inj ected mice. No significant association between inj ury location 
and paw touching w ith the affected paw was found at 3 days (R2=0 .000, p=0.962, 
slope=0.001), 1 week (R2=0.003, p=0.733 , slope= 0.009) or at 2 weeks (R2=0.0 17. 
p=0.447, slope=-0.024). (n=38) 
C) Regression analysis of coverage of the 60- 100% FMC core at 2: 80% cortical depth of 
infarcted tissue vs cylinder data for ET-1 injected mice. No significan t association 
between injury location and paw touching with the affected paw was found at 3 days 
(R2=0.003, p=0.734, s lope=-0.01 0), 1 week (R2=0.000, p=0.961 , slope=0.002) or at 2 
weeks (R2=0.051 , p=0.186, slope=-0.049) . (n=38) 
D) Regression analysis of coverage of the 60-1 00% FMC core at 2: 60% cortical depth of 
infarcted tissue vs cylinder data for ET-1 injected mice. No significant association 
between injury location and paw touching with the affected paw was found at 3 days 
(R2=0.001, p=0.843 , s lope=0.006), 1 week (R2=0.001 , p=0.891 , slope=0.004) or at 2 
weeks (R2=0.055 , p=0. 170, s lope=-0.050). (n=38) 
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Paw-dragging behaviour was quantified as a percentage of cylinder touches 
resulting in a paw-drag o ut of the total number of cy I i nder touches fo r ET- 1 injected 
mice. Paw-draggi ng behaviour increased signifi cantl y at 3 days post injection fo llowing 2 
and 3 injections of ET-1 (Fig 3. 11 A,B). While paw-dragging behaviour tends to peak at 3 
days post-injection and recover thereafter, mice recei ving 3 injections of ET- 1 (Fig 
3.11 B) had a much slower recovery rate than mice receiving 2 injections of ET-1 (Fig 
3.11 A). with their paw-dragging behaviour remaining s ignificantly higher than baseline 
at 14 days post injection. This suggests that 3-injections of ET- 1 may be a better injection 
protocol for use in studying long-term behavioural defi cits. As paw-dragging peaks at 3 
days post-injection, further study should be taken to determine whether it correlates wi th 
long-te rm staircase deficits. This could be used as an earl y inclusionary criterion, 
allowing experimental treatments to be started sooner post-ischemia. 
While paw-dragging is e levated after ET- 1 injection, it is not clear whether there 
is a relationship between FMC damage and paw-dragging. The e levated paw-dragging 
may not be a result of damage to the FMC, but rather a side effect of damage to the 
forelimb sensorimotor cortex which abuts the FMC. Comparing paw-dragging behaviour 
to coverage of the FMC60_100 at 2:60% depth with a regression analysis, a significant 
relationship emerges whereby paw-dragging observed at 3 and 14 days post-injection 
increases as core coverage increases (Fig 3. 11 C) . By performing another regression 
analys is using coverage of the FMC4o- 1oo area at 2:60% depth, the relationship between 
core coverage and paw-dragging is significant at 3, 7 and 14 days post-injection, and the 
slopes are strongest at each time point (m=0.393 at 3d, m=0.240 at 1 week, m=0.293 at 2 
weeks, Fig 3. 110). 
!\regression analysis was performed comparing staircase deficits at one week 
post-injection (normalized to pre-injection behaviour) with paw-d ragging at 3 and 7 days 
post-injection. While the re seems to be a trend at 3 days post-injection (m- 0.148, 
R2=0.076, p=0.1 2), there is a significant correlation between a deficit in staircase 
reaching at one week and increased paw-dragging at 7 days post- injectio n (m=O.l 26, 
R2=0. 145 , p<O.OS, Fig 3. 11 £). While staircase and cylinder tests both measure fo relimb 
motor defic iency in mice, this analysis demonstrates that the two tests are s imilar with 
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Figure 3. 10: Mouse cylinder test paw-dragging behaviour. 
A-D) Representati ve pho tographs o f a mouse perfo rming a cylinder rear without forel imb 
motor deficits. Photos are taken in succession from a video recording. 
E-H) Representative photographs of a mouse perfo rming a paw-drag. Photos are taken in 
succession from a video recording. Black arrows indicate the affected forepaw. 
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Figure 3. 11 : Paw-dragging analysis of the mouse cylinder test correlates w ith infa rcts in 
the FMC. 
A) Analysis of cylinder paw-dragging data fo r 2 cortical injections. (n=8 Saline, n=24 
ET-1 ) 
B) Analysis of cylinder paw-dragging data fo r 3 cortical inj ections . (n= l 3 Saline, n= l 6 
ET-1 ) 
C) Regression analysis of depth maps of the FMC6o.Joo at 2:60% cortical depth of 
infarcted tissue vs paw-dragging data lo r ET-1 injected mice at 3 days (R2=0 .1 95 , p<O.O 1, 
s lope=0.269). 1 week (R2=0.066, p=0.11 5, slope=O. l 22) or at 2 weeks (R2=0.182, 
p<O. O I , slope=0.226). (n=39). 
D) Regression analys is of depth maps of the FMC4o-1oo at 2:60% cortical depth of 
infarcted tissue vs paw-dragging data for ET-1 inj ected mice at 3 days (R2=0.242, p<O.O 1, 
slope=0.393). l week (R 2=0. l49. p<O.OS, slope=0.240) or at 2 weeks (R2=0. 191, p<O.O l , 
s lope=0.293). (n=39). 
E) Regression analys is of I week sta ircase defi cits vs 3 day (R2=0.076. p=O. l22, 
slope=O. l 48) and 7 day (R2=0. 145, p<O.OS, slope=0 .1 26) paw-dragging for ET- 1 injected 
mice. (n=34) *p<O.OS, **p<0.01, *** p<0.00 1 
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respect to one another - something that should be expected if both tests seek the same 
re lationship (increased core coverage with increased behavioural defi cits). Despi te these 
tests mildly relating to one another, the fact that they are both sensitive to FMC damage 
means that there is a greater chance that functi onal recovery can be observed when usi ng 
both tests in a therapeuti c experiment. 
3.6 - Paw-dragging does not corre late w ith infarcts in ei ther the anterior or posterior FMC 
alone. 
When comparing paw-dragging behaviour to coverage of the anteri or FMC, there 
was no corre lation. When comparing behaviour to core coverage in the FMC6o-1 oo at 
2:80% depth (Fig 3. 12A), at 2:60% depth (Fig 3.12C) and of the FMC10-1 00 at 2:60% depth 
(Fig 3. l2E) the re were no corre lati ons. There was a significant relationship at 14 days 
when comparing coverage of the posterior FMC6o-1oo at 2:80% depth (Fig 3 .1 28 ), 2:60% 
depth (Fig 3. 120 ) and the FMC40_100 at 2:60% depth (:Fig 3. 12F) to paw-dragging 
behaviour. These correlati ons, despite being significant , take place w ithin a very narrow 
range of paw-dragging values - because of thi s, determining c riteria based on these data 
may not be possible . While s ignificant relationships emerge, the slope is q uite low 
signifying that large injuries encompass ing most of the FMC as a whole are conducive to 
paw-dragging behavio ur. 
3.7 - ET- 1 infarcts in the FMC ind uce NPC pro li fe ration and migrati on toward the 
ischemic cortex . 
While ET- 1 can produce behavioural de fi ci ts when targeted to the FMC, there are 
other considerations in developing an injury model. W hen considering therapy 
manipulating PCs to regenerate infarcted neural tissue, it must be known whether NPCs 
endogenously repa ir small focal cerebra l infarcts. While NPCs have been shown to 
migrate and di fferentiate into neurons after MCAO, the questi on must be asked again as 
ET-1 infarcts are smaller than those resulting from MCAO. Therefore, whether ET- 1 
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Figure 3. 12: Paw-dragging is not associated with ET-1 infarcts specifically in the anterior 
FMC. 
A) Regression analysis of coverage of the anterior FMC6o-1oo at ~80% cortical depth of 
infarcted tissue vs paw-dragging data for ET- 1 injected mice at 3 days (R2=0.0 14, 
p=0.472, slope=0.065), 1 week (R2=0.032, p=0.267, s lope=0.071 ) or at 2 weeks 
(R2=0.003. p=0.742, s lope=0.02 1 ). (n=40) 
B) Regression anal ysis of coverage of the poste rior FMC60. 100 at ~80% cortical depth of 
infarcted tissue vs paw-dragging data for ET- 1 injected mice at 3 days (R2=0.046, 
p=0. 183 , slope=O.l 08), 1 week (R2=0.022, p=0.361 , slope=0.052) or at 2 weeks 
(R2=0.208, p<0.0 1, slope=0.16 1). (n=40). 
C) Regression analysis of coverage of the anterior FMC6o.1oo at ~60% cortical depth of 
infarcted tissue vs paw-d raggi ng data for ET-1 injected mice at 3 days (R2=0.091 , 
p=0.059. slope=0. 159), I week (R2=0.059, p=0.130, slope=0.090) or at 2 weeks 
? (R-=0.008, p=0.592, s lope=0.032). (n=40) 
D) Regression analysis of coverage of the posterior FMC60. 100 at ~60% cortica l depth of 
infarcted tissue vs paw-dragging data fo r ET- 1 injected mice at 3 days (R2=0.073 , 
p=0.092, slope=0. 124 ), 1 week (R2=0.00 1, p=0.819, s lope=O.O 12) or at 2 weeks 
2 (R =0.192, p<0.0 1, slope=0.141). (n=40). 
E) Regression analysis o f coverage of the anterior FMC10_100 at ~60% cortical depth of 
infarcted ti ssue vs paw-d ragging data for ET- 1 injected mice at 3 days (R2=0.070, 
p=0.099, slope=O.l74), 1 week (R2=0.076, p=0.086, slope=0.127) or at 2 weeks 
) (R-=o.ooo, p=0.971 ' slope=-0 .003). (n=40) 
F) Regression analysis of coverage of the posterior FMC40.100 at ~60% cortical depth of 
infarcted tissue vs paw-dragg ing data for ET-1 injected mice at 3 days (R2=0.090, 
p=0.060, slope=0.173), 1 week (R2=0.062, p=0. 12 1, s lope= O. l Ol) or at 2 weeks 
(R2=0.3 14, p<O.OOl , s lopc=0.226). (n=40) **p<O.Ol , ***p<O.OO l 
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infarcts in the FMC promote NPC proliferation and migration toward the ischemic cortex 
was assessed. To study this, daily BrdU injections were given on post-surgery days 4-8, 
labeling NPCs undergoing terminal mitosis. By observ ing Dcx+/BrdU+ cells o utside o f 
the SVZ, NPC migration can be quantified. Dcx+ BrdU double-labeled cell s were 
shown migrating from the SVZ toward the infarct, demonstrating that Dcx+ neuroblasts 
born on days 4-8 post-injection leave the SVZ and migrate toward ischemic injury (Fig 
3.13A). Pro liferation can be assessed by analyzing the number of Dcx+ neuroblasts in the 
ipsilatera l SVZ as opposed to the contralateral SVZ. While this assay does not measure 
the number of proliferating cells, it measures an increase in the number of Dcx+ 
neuroblasts generated which likely result from increased NPC proliferation. The diagram 
in Fig 3. 138 encloses the latera l ventricle and SVZ, ou tside w hich neuroblasts are said to 
be migrating toward the inj ured ti ssue. An increase in the number of Dcx+ cells in the 
SVZ was observed ipsilateral to the injury, compared to the contralateral SVZ, suggesti ng 
that increased NPC proliferation has occurred and/or is occurring in response to ischemic 
injury (Fig 3.1 3C). While Dcx+ ce ll numbers are increased in the cortex ipsilateral to the 
injury, migration of Dcx+ cells away from the SVZ was compared to that in the 
contra lateral cortex. T here were a signifi cant number of Dcx neuroblasts migrating 
toward the injury at 0-1 501-lm from the SVZ (Fig 3 . l 3D). Neuroblasts are found further 
than I S0 11m from the SVZ, but the ir numbers were variable, suggesti ng that they ei ther 
die or di fferentiate into Dcx- neurons. Together, these results suggest that a significant 
number of neuroblasts migrate toward the injured cortex and corpus callosum. 
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Figure 3. 13 Neural precursor cells proliferate and migrate toward an ET-1 induced 
cortical ischemic injury. 
A) Immunohi stochemistry for Dcx+(green) and BrdU+(red) cell s in the inj ured 
hemisphere . 
B) Right cerebra l hemisphere depicting SVZ in red boxed area. Cells fou nd outside th is 
area were counted as migrating (adapted from Doetsch et a l., 1999). 
C) Comparing the number of Dcx+ cells in the SVZ between injured and uninjured 
hemispheres (n=7) . 
D) Comparing the number of Dcx+ cell s migrating away from the SVZ in l50~Lm 
increments from the SVZ in injured and uninjured hemispheres (n=7) . 
FdistancJ3 ,72)=3.56, *p<O.OS 
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Chapter 4: Discussion 
In this study it was shown that a reproducible ET-1 induced ischemic injury can 
be produced in the mouse cerebral cortex whi ch correlates with behavioural deficits . The 
mouse staircase test was shown to correlate with location and depth of an ET-1 induced 
ischemic injury in the mouse FMC. The FMC was also shown to be functional ly 
subdiv ided: damage in the anterior FMC is highly correlated w ith deficits in the mouse 
staircase while damage in the posterior FMC is not. This study confirms previous studies 
showing that analysis of percentage of affected paw use in the cyl inder test of forelimb 
asymmetry does not corre late w ith ET-1 injury in the FMC. T-:Iowever, I developed a 
novel analysis of the mouse cylinder test. "paw-dragging"", which does corre late with an 
ET- 1 induced ischemic injury to the FMC. Addi tionally, ET-1 induced ischemic injury is 
associated with greater numbers of SVZ PCs and their migrative response. An increase 
in the number of Doublecortin+ NPCs in the ipsilateral SVZ and corpus callosum was 
observed two weeks after an ET-1 induced ischemic injury, demonstrating that NPCs are 
migrating toward the injury s ite. These findings demonstrate that a focal ischemic injury 
in the mouse FMC correlates wi th behavioural tests , and that SVZ NPCs migrate toward 
the injured cortex. 
4. 1 - A model of ET-1 induced ischemic injury has been produced in the mouse 
In assessing PC mediated regeneration oC cortical tissue in the mouse, an injury 
mode l must be developed such that the inj ury is consistently associated with behavioural 
deficits but small enough to be repaired. Due to this, creating an injury model using focal 
ET- 1 induced ischemic injuries would be most appropriate in assessing NPC mediated 
regeneration of cortical tissue. Other types of injury, such as MCAO induced ischemia, 
produce much larger injuries encompassing much of the striatum and lateral cerebral 
cortex (Tamura et a l. , 1981) and may prove more difficult to regenerate lost neural ti ssue. 
While ET- 1 is a potent vasoconstrictor, a potential drawback to using exogenous ET-1 is 
that it re lies on pharmacological intervention, creating levels of ET- 1 which wou ld never 
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ordinarily occur in vivo. ET-1 affects other cell types due to the ET-B receptor being 
present in N PCs and cortical astrocytes - this can cause the re lease of fac tors affecting 
vascul ar permeability and astrocyte proliferation (Koyama et a!. , 20 12; N ishikawa et al. , 
2011 ). However, the contro llable size and ability to target the injury to a specific location 
allows it to answer questions that may be more challenging to address using MCAO, such 
as whether therapies involving NPCs can improve functional recovery. 
Consistent with the demands of the model, ET-1 produces a small but significant 
infa rct size and these experiments show that it produces measurab le behavioural deficits 
on the sta ircase and mouse cylinder tests. The concentration of ET- 1 used here (2flg/~d) 
was hi gher than that used in other studies of ET-1 injections in the mouse cortex. though 
injections made herein using the lower concentration of ET-1 (1 ~tg/fll) were difficul t to 
resolve and did not seem to produce a reliable behavioural deficit (Wang et al. , 2007b, 
Tennant et a l. , 2009, Sozmen et al. , 2009). The infarct size is dependent on the number of 
injections, demonstrating that the size of injuries are controllab le and that cortical regions 
of interest can be damaged while sparing other regions. The abil ity to specify the size and 
location of the injury make ET- 1 induced ischemia a more desi rable model than others 
when assessing regeneration of cortical tissue in mice. 
4.2 - Mouse staircase behaviour correlates with the location of ET-1 infarcts 
This study is the first to demonstrate that the mouse staircase test correlates wi th 
FMC damage after ET- 1 induced ischemic injury. While the mouse staircase test is 
effective in predicting MCAO induced ischemic injury and cortica l aspiration lesions, it 
was unclear w hether a small er foca l injury could reliably induce significant deficits 
(Baird et al. , 200 1, Bouet et al. , 2007). The stai rcase test is effective in predicting MCAO 
and ET- 1 induced ischemic injuries in rats as well ; however, thi s may be due to the fact 
that ET-1 produces larger infarcts in rats than in mice, encompassing a wider brain 
volume and damaging multiple functi onal circuits (Wi ndle et al. , 2006). These 
experiments demonstrate that precise targeting of ET- 1 to forelimb representations in the 
mouse motor cortex produces a significant behavioural deficit, despite the fact that ET-1 
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induced inrarcts arc much smaller than MCJ\0 induced infarcts. 
The mouse staircase test specifically correlates with inj ury in the anterior FMC. 
This is consistent with recent findings that abduction of the mouse forelimb is a result of 
activity in the anterior FMC while adduction of the forelimb is a result of activity in the 
posterior FMC (Harri son et a!.. 20 12). It is difficult to di rectly compare stai rcase reaching 
\ ith forelimb abduction because fo relimb reaching involves a series of movements and 
several muscle groups. I Iowever. both movements share an anterior movement of the 
forelimb, suggesting that a common representat ion may ex ist in the FMC. These resu lts 
supply additional information on the mouse FMC map developed by Tennant & 
colleagues as well as the mouse motor cortex region by Franklin & Pax inos (Franklin & 
Pax inos., 2004, Tennant et al. , 20 II ). Additionally, by examining onl y mice which ha e 
anterior FMC damage, I have shown that these animals have significantly larger staircase 
deficits than ET-1 injected animals with damage outside the anterior I· MC ( .. OFF-target"· 
injuries). Whi le there is no significant difference between sa line-injected animals and 
ON-target ET- 1 injected animals at 2 weeks, this is largely because there is more 
variability in groups once they have been split into thei r 0 and OFF-target groups, 
respecti vely. Increasing the number of mice in thi s analysis would be a large undertaking, 
but it would be expected that ET-1 ON-target injections would have significantly larger 
staircase defi cits than other groups. Demonstrating the regional functi onality in the FMC 
holds promise not only in understanding the organi zation of the mouse motor cortex. but 
also in developing and refining models of cortical injury. 
4.3 - Paw-dragging beha iour correlates with the location of ET- 1 infarcts 
In addition to the staircase test. paw-dragging analys is of the mouse cylinder test 
correlates highl y with FMC injury. Paw-dragging analysis is useful in that it is more 
sensitive to FMC damage than forelimb asymmetry analysis, which showed no deficits in 
this study a fter ET- 1 injection. While fo relimb asymmetry deficits are apparent after 
larger infarcts such as MCAO, smaller infarc ts such as ET- 1 induced cortical injury do 
not show deficits in forelimb asymmetry (Tennant et al. , 2009). This reinforces the idea 
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that the size of infarct as well as location may be a major determinant of deficit. Paw-
dragging may have a niche use in smaller injuries where fo re limb asymmetry is not 
useful (as opposed to larger injuri es where fore limb asymmetry deficits correlate with 
damage). 
Paw-dragging deficits tend to recover somewhat over time a fter either two or 
three injections of ET-1 . However, paw-dragging behaviour is still significantly elevated 
at 14 days in the 3 injection group, w hile paw-dragging behaviour is only elevated after 3 
days in the 2 injection group. This demonstrates that paw-dragging is sensitive to small 
changes in the amount of damage to the FMC, and greater damage produces more 
sustained deficits. The pattern of recovery of functi on afte r 2-injcctions is similar to 
studies showing that, post-MCAO, rats tend to have greater forelimb asymmetry deficits 
at 2 days post-MCJ\0 then recover some function at I week post-MCJ\0 (Encarnacion et 
al. , 20 11 ). Paw-dragging may also find use in other types of focal ischemic injury models 
such as those induced by photothrombosis. Further study is required to determine how 
inclusionary criteria can be developed from thi s highl y sensiti ve test of fore limb motor 
deficit. 
Paw-draggi ng has been shown here to correlate positively. albe it weakly. with 
staircase retrieval. As paw-dragging does not seem to ari se specifically from anterior 
FMC damage, it is likely that paw-dragging and stai rcase deficits arise fro m damage to 
different subdi vis ions of the FMC. As both tests are responsive to FMC damage, this 
a llows for each test to potentially respond to damage that the othe r wouldn't, increasi ng 
the chances that an infarc t has a behavioura l corre late. It is possible that paw-dragging 
results from damage to the forel imb sensorimotor cortex, though thi s has not been 
examined in this study. T he fact that pa -dragging is observed at some le e l in every 
mouse given an FMC injection of ET- 1 suggests o therw ise, thoug h more investigation is 
needed. 
4.4 - NP C proliferati on and migration in response to ET- 1 infarcts 
PC proliferation after ET- 1 induced ischemic injury has previously been 
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demonstrated in mice 3 days post-ischemia (Wang et al. , 2007b). While my ex periments 
demonstrate increased Dcx+ cells in the SVZ at l4d post-ischemia, both studies 
demonstrate increased Dcx+ SVZ neuroblasts following cortical T-1 injections. This 
lends support to the theory that cortical ischemia can induce proliferation, though a true 
proliferation assay must be performed. Hav ing an increased pool of neuroblasts which 
migrate toward the infa rct and regenerate lost tissue is an advantage when using stroke 
therapies focused on fortify ing SVZ neuroblasts w ith pro-survival factors. 
While PCs are known to proliferate and mi grate toward a large C S inj ury such 
as MCAO, thi s study demonstrates that a foc al ET-1 induced cortical ischemic injury is 
associated with neurobl ast migration in the mouse. The vo lume of mi grating neuroblasts 
peaks between 7 and 14 days post-MCAO in the rat (Arvidsson et al. , 2002) . While the 
peak volume o f mi gratio n has not been assessed w ith smaller ET- 1 injuries in m ice, my 
results show that there is st ill a measurable response at 14 days post-ischemia. A 
significant increase in the number of neuroblasts in the corpus callosum of the injured 
he misphere was observed when assessing only neuroblasts within 1 50~Lm from the edge 
of the SVZ. furthermore, there are fewer neuroblasts and more variability in their 
numbers as the distance from the SVZ increases. This may be due to a number of reasons, 
including neuroblasts moving into the cortex where there may be an increased probabil ity 
of apoptosis. furthermore. some neuroblasts may have a lready differentiated into mature 
ne urons, in which case Dcx would no longer be expressed. /\s neurob1asts migrate c loser 
to the injured cortex, both ofthese possibilities would seem more likely. Despite some 
uncertainty as to the ir fate. the mi gration o f N PCs into the damaged cortex is evident, 
allowing future studies to develop therapies targeting and modifying NPCs. 
4.5 - S ummary 
In summary, it has been shown that ET-l produces a reproducible foca l ischemic 
cortica l injury in the mouse FMC . This study is the first to link increasing damage to the 
FMC to defic its in the staircase test. Moreover, thi s study demonstrates that the staircase 
test corre lates with anterior FMC damage rather than posterior 1~ MC damage - a 
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phenomenon which may be explained by recent work examining subdivisions of the 
mouse FMC (I farri son et a!. , 20 12). A new assessment of the mouse cylinder test - paw-
dragging - has been developed which correlates with ET-1 induced ischemic injury in the 
1~ MC. This test is highl y sensitive to inj ury within the mouse FMC and, with further 
study. can be used as an early measurement tool to exclude un inj ured mice from future 
regeneration studies. Finally, for future stud ies investi gating PC mediated regeneration 
or cortical ti sue, it has been shown that ET- 1 induced ischemic injury elicits an 
endogenous neurogenic response in the mouse cortex . An increased number of Ocx 
neuroblasts in the SVZ of injured mice were observed. As well , PC migration toward an 
ET-1 induced focal ischemic inj ury has been observed in the mouse for the first time. 
These findi ngs will a llow investigators to use a wide variety of transgenic mice to 
investigate therapies for cortical ischemia. This work will allow signi ficant strides to be 
made in mouse regenerati ve medicine and, from thi s. a hurdle toward developing new 
therapies is removed. 
4.6 - f uture direction 
While thi s model of ischemic injury incl udes quantifiable de fi cits on the mouse 
staircase test and cylinder test, there are some considerations that must be met before it 
can be used to study regenerative therapies us ing PCs. 
The first consideration is that the model only observes defici ts up to 14 days post-
injection. Future work will need to observe long term deficits in order to model long term 
defi cits in humans after ischemic stroke. This experiment wi ll in ol e three injections or 
ET"-1 , but will continue to test mice on both behavioural tests up to 28 days post-injection. 
Staircase and cylinder testing will occur every week including 21 and 28 days post-
injection. By developing a long-lasting behavioural defici t. one can assess recovery of 
function with d i ffercnt regenerati vc therapies. 
The second consideration is that during this experiment, the anterior FMC was 
identified as be ing responsible fo r motor movements crucial fo r stai rcase pellet retrieval. 
This region is slightly anterior to the target of the current injection sites: the 80-100% 
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FMC core. Deficits in this test sho uld be made more pronounced , as the effect size is 
significant but smal l. Future experiments will need to modify the injection sites such that 
the anterior FMC can be maxi mally damaged. As infarcts covering the majori ty of the 
anterior FMC produce modest defi cits on the staircase test, adjusting the injection sites to 
maximize infarct coverage wi ll be crucial in order to observe functional recovery 
afterward. This could be achieved by adding additional injections of ET- 1 or by 
increasing the spacing between injections to create a broader injury encompassing most 
of the anterior FMC. By consistently damaging the anterior FMC, it may be possible to 
produce more pronounced behavio ural deficits more frequently and reduce inter-animal 
variabi lity. Beyond refinement o f the injury mode l however, regenerative therapies must 
be developed. 
After an injury model is refined, therapies promoting neural regeneration can take 
advantage of it. T here are some issues with the endogenous neurogenic response to injury 
that may need to be dealt with before an effecti ve therapy is produced. 
It has already been demonstrated that N PCs can migrate toward a site of injury 
and diffe rentiate into locally relevant subtypes: namely, SVZ neuroblasts differentiating 
into OARPP32+ medium spiny neurons which are specific to the striatum (Arvidsson et 
al. , 2002). Critics of this view may note that medium spiny neurons in the striatum are 
still GABAergic , and are more similar to the NPCs which normal ly give rise to 
GABAergic granule cells in the olfactory bulb (Whitman & Greer, 2009). However, 
PCs in the dorsal horn of the SVZ display a phenotype consistent with early 
g lutamate rgic cortical precursors and can diffe rentiate into glutamate rgic neurons in vitro 
(Brill et al. , 2009). This suggests that two factors can affect the subtype of an adult born 
neuron: cues local to the region that it migrates into , and cues within the SVZ which 
promote subtype specification. How these two factors interact to produce specific 
neuronal subtypes after ischemic stroke is not yet clear. Recently, Shh release from 
neurons in the ventral septum was shown to affect NPC subtype specification in the adult 
SYZ (Ihrie et al. , 20 11 ). Despite subtype specificati on being a valid concern fo r a model 
of neural regeneration, thi s evidence suggests that cell s may differentiate into relevant 
subtypes without the need for external intervention. Integration into the appropriate 
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neural circuits, however, is another concern . While interneurons may have less difficulty 
forming new synapses, neurons in layers normally projecting subcorticall y or 
interhemispherally may not be able to recapitulate axon guidance that occurs during 
development. Whether thi s is possible or not is not yet known. 
Aside from issues regarding subtype specification, other issues arise when trying 
to fortify PCs using gene therapy. In order to test whether Mcl-1 can improve survival 
of migrating PCs, further study must identify peak PC migration times as well as the 
most efficient route ofNPC transfection or infection. Two routes which hold promise for 
deli very of pro-survival factors such as Mcl-1 arc adult electroporation and retroviral 
infection (Barnabe-Heider et al. , 2008; Goings et al. , 2004). Assessing rates of 
transduction will be key in determining which method is optimum. As we ll , since Mel- I 
promotes cell cycle exit in NPCs, expressing Mcl-1 from a Dcx promoter in neuroblasts 
may prevent Mcl-1 from causing 8 and C cells to prematurely differentiate, allowing 
expansion of the PC population (Hasan et al. , in press, Wang et al. , 2007a). While 
creation of a transgenic Dcx-Mcl-1 mouse may be the most efficient way of ensuring 
Mcl-1 is expressed in neuroblasts, there is significant cost overhead in producing and 
maintaining transgenic mouse strains. 
Regenerati ve therapies continue to be developed and refined in animal models. Of 
these therapeutic studies, many shovv degrees of functional recovery within subjects. 
Some studies show that while PC migrati on and/or grafts integrate somewhat with local 
circuits they provide trophic support fo r damaged cel ls by emi tt ing growth fac tors 
(Doeppner et a l. , 201 0). While mod ifying endogenous NPCs is an attractive avenue for 
therapy, NPC grafts may be a more attractive human therapy as PCs can be injected at 
the site of interest and genetic modifications can be performed prior to surgery. Whether 
NPCs integrate into circuits or simply provide trophic support to injured cel ls in the peri-
infarct cortex wi ll need to be determined. The consensus favours therapeutic 
interventions using PCs rather than not using PCs when aiming for fu nctional 
recovery. By improving the survival ofNPCs, they may integrate into local circuits or 
simply provide trophic support over a longer period of time. Potentially, Mcl-1 has the 
ability to improve prognosis post-stroke via either process. 
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Despi te a number of challenges, the case fo r neural regeneration remains strong. 
From thi s work, the model should continue to be refi ned until the set of injection si tes 
al low for an ischemic injury covering the re levant cortical areas wh ile minimaliz ing 
damage to unrelated cortical areas. Furthe rmore, the injury model must be val idated in 
the long-term such that the benefit s can be detected from the prolonged generation of 
adult born neurons. C ha llenges such as gene transduction efficiencies and peak migration 
times must be identified and taken advantage of. but are reali st ic goals. As well , the 
chal lenge of subtype specification may even be moot, as the fate of NPCs is reasonably 
plastic post-stroke, and there is even a diversity of subtypes wi thin the SVZ. Despite 
there being challenges in developing neura l regeneration therapies, the evidence is 
encouraging that neural regeneration matters, and it is quite clear that these chal lenges 
must be met in order to maximize success. 
Thi s work is currently being prepa red for publication. 
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